10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________________

FORM 10-Q

_________________________________________

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended April 29, 2017 OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 0-19714

_________________________________________

PERFUMANIA HOLDINGS, INC.

(Exact name of Registrant as specified in its charter)

_________________________________________

Florida	65-0977964
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

35 Sawgrass Drive, Suite 2 Bellport, NY	11713
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (631) 866-4100

_________________________________

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  R    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  R    No   ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer”, “accelerated filer" and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):

Large Accelerated Filer	o	Accelerated Filer	¨
Non-accelerated Filer	o  (Do not check if a smaller reporting company)	Smaller Reporting Company	þ
Emerging Growth Company	o
If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  R

The number of shares outstanding of the registrant’s common stock, as of the latest practicable date: At June 16, 2017, there were 15,493,763 outstanding shares of its common stock, $0.01 par value.

TABLE OF CONTENTS

PERFUMANIA HOLDINGS, INC. AND SUBSIDIARIES

PART I

FINANCIAL INFORMATION

ITEM 1	FINANCIAL STATEMENTS	3
	Condensed Consolidated Balance Sheets as of April 29, 2017 (unaudited) and January 28, 2017	3
	Condensed Consolidated Statements of Operations for the thirteen weeks ended April 29, 2017 and April 30, 2016 (unaudited)	4
	Condensed Consolidated Statement of Shareholders' Equity for the thirteen weeks ended April 29, 2017 (unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the thirteen weeks ended April 29, 2017 and April 30, 2016 (unaudited)	6
	Notes to Condensed Consolidated Financial Statements (unaudited)	7
ITEM 2	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	15
ITEM 3	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	19
ITEM 4	CONTROLS AND PROCEDURES	19
	PART II OTHER INFORMATION
ITEM 1	LEGAL PROCEEDINGS	19
ITEM 1A	RISK FACTORS	20
ITEM 2	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	20
ITEM 3	DEFAULTS UPON SENIOR SECURITIES	20
ITEM 4	MINE SAFETY DISCLOSURES	20
ITEM 5	OTHER INFORMATION	20
ITEM 6	EXHIBITS	21
	SIGNATURES	22

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

PERFUMANIA HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	April 29, 2017			January 28, 2017
	(unaudited)			(Note 1)
ASSETS:
Current assets:
Cash and cash equivalents	$	1,848		$	7,474
Accounts receivable, net of allowances of $2,427 and $2,267 as of April 29, 2017 and January 28, 2017, respectively	31,614			28,072
Inventories	193,083			196,654
Prepaid expenses and other current assets	9,829			10,619
Total current assets	236,374			242,819
Property and equipment, net	15,818			16,692
Goodwill	38,769			38,769
Intangible and other assets, net	13,778			14,520
Total assets	$	304,739		$	312,800
LIABILITIES AND SHAREHOLDERS’ EQUITY:
Current liabilities:
Accounts payable	$	27,506		$	28,605
Accounts payable-affiliates	546			1,027
Accrued expenses and other liabilities	28,507			31,186
Current portion of obligations under capital leases	898			1,237
Total current liabilities	57,457			62,055
Revolving credit facility	4,517			—
Notes payable-affiliates	125,366			125,366
Other long-term liabilities	66,593			64,954
Total liabilities	253,933			252,375
Commitments and contingencies
Shareholders’ equity:
Preferred stock, $0.10 par value, 1,000,000 shares authorized; as of April 29, 2017 and January 28, 2017, none issued	—			—
Common stock, $.01 par value, 35,000,000 shares authorized; 16,392,012 shares issued as of April 29, 2017 and January 28, 2017	164			164
Additional paid-in capital	222,082			222,048
Accumulated deficit	(162,863		)	(153,210		)
Treasury stock, at cost, 898,249 shares as of April 29, 2017 and January 28, 2017	(8,577		)	(8,577		)
Total shareholders’ equity	50,806			60,425
Total liabilities and shareholders’ equity	$	304,739		$	312,800

See accompanying notes to condensed consolidated financial statements.

3

PERFUMANIA HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands, except share and per share amounts)

	Thirteen Weeks Ended April 29, 2017			Thirteen Weeks Ended April 30, 2016
Net sales	$	97,896		$	105,139
Cost of goods sold	52,927			53,370
Gross profit	44,969			51,769
Operating expenses:
Selling, general and administrative expenses	50,932			53,928
Share-based compensation expense	34			32
Depreciation and amortization	1,531			2,511
Total operating expenses	52,497			56,471
Loss from operations	(7,528		)	(4,702		)
Interest expense	2,125			1,707
Loss before income tax provision	(9,653		)	(6,409		)
Income tax provision	—			—
Net loss	$	(9,653	)	$	(6,409	)
Net loss per common share:
Basic and diluted	$	(0.62	)	$	(0.41	)
Weighted average number of common shares outstanding:
Basic	15,493,763			15,493,763
Diluted	15,493,763			15,493,763

See accompanying notes to condensed consolidated financial statements.

4

PERFUMANIA HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

(Unaudited)

(in thousands, except share amounts)

				Additional
	Common Stock			Paid-In		Accumulated			Treasury Stock
	Shares	Amount		Capital		Deficit			Shares	Amount			Total
Balance at January 28, 2017	16,392,012	$	164	$	222,048	$	(153,210	)	898,249	$	(8,577	)	$	60,425
Share-based compensation expense	—	—		34		—			—	—			34
Net loss	—	—		—		(9,653		)	—	—			(9,653		)
Balance at April 29, 2017	16,392,012	$	164	$	222,082	$	(162,863	)	898,249	$	(8,577	)	$	50,806

See accompanying notes to condensed consolidated financial statements.

5

PERFUMANIA HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(in thousands)

	Thirteen Weeks Ended April 29, 2017			Thirteen Weeks Ended April 30, 2016
Cash flows from operating activities:
Net loss	$	(9,653	)	$	(6,409	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred financing costs	86			86
Depreciation and amortization	1,531			2,511
Provision for losses on accounts receivable	164			1,787
Share-based compensation	34			32
Changes in operating assets and liabilities:
Accounts receivable	(3,706		)	(7,181		)
Inventories	3,571			7,487
Prepaid expenses and other assets	1,084			405
Accounts payable	(1,099		)	1,919
Accounts payable-affiliates	(481		)	(120		)
Accrued expenses and other liabilities and other long-term liabilities	(1,040		)	(1,187		)
Net cash used in operating activities	(9,509		)	(670		)
Cash flows from investing activities:
Additions to property and equipment	(295		)	(809		)
Net cash used in investing activities	(295		)	(809		)
Cash flows from financing activities:
Net borrowings (repayments) under bank line of credit	4,517			(989		)
Principal payments under capital lease obligations	(339		)	(285		)
Net cash provided by (used in) financing activities	4,178			(1,274		)
Net decrease in cash and cash equivalents	(5,626		)	(2,753		)
Cash and cash equivalents at beginning of period	7,474			5,640
Cash and cash equivalents at end of period	$	1,848		$	2,887
Supplemental Information:
Cash paid during the period for:
Interest	$	71		$	214
Income taxes	$	17		$	109

See accompanying notes to condensed consolidated financial statements.

6

PERFUMANIA HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 - BASIS OF PRESENTATION AND OPERATIONS

The condensed consolidated balance sheet of Perfumania Holdings, Inc. and Subsidiaries (the "Company") as of January 28, 2017, which has been derived from our audited financial statements as of and for the year ended January 28, 2017, and the accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. Certain information and note disclosures normally included in annual financial statements, prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), have been condensed or omitted pursuant to those rules and regulations. The financial information presented herein, which is not necessarily indicative of results to be expected for the full current fiscal year, reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the interim unaudited condensed consolidated financial statements. Such adjustments are of a normal, recurring nature. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended January 28, 2017.

Due to the seasonality of the Company’s business, with the most significant activity occurring from September through December each year, the results of operations for the thirteen weeks ended April 29, 2017 are not necessarily indicative of results to be expected for the full fiscal year.

The Company is an independent, national, vertically integrated wholesale distributor and specialty retailer of perfumes and fragrances that conducts business through six wholly-owned operating subsidiaries; Perfumania, Inc. (“Perfumania”), Quality King Fragrance, Inc. (“QFG”), Perfumania.com, Inc. (“Perfumania.com”), Parlux Fragrances, LLC ("Parlux"), Five Star Fragrance Company, Inc. (“Five Star”) and Scents of Worth, Inc. ("SOW"). We operate in two industry segments, wholesale distribution and specialty retail sales of designer fragrances and related products.

Our wholesale businesses include QFG, Parlux and Five Star. QFG distributes designer fragrances to mass market retailers, drug and other chain stores, retail wholesale clubs, traditional wholesalers, and other distributors throughout the United States. The Company sells principally to retailers such as Burlington Coat Factory, CVS, Kohl's, Marshalls, Nordstrom Rack, Ross Stores, Sears, Target, Wal-Mart and Walgreens. The Company’s manufacturing divisions, Parlux and Five Star, own and license designer and other fragrance brands that are sold to regional and national department stores, including Belk, Bon Ton, Boscovs, Dillards, Lord & Taylor, Macy's and Stage Stores, international distributors, on military bases throughout the United States, by QFG and through the Company's retail business which is discussed below. Parlux also fulfills a selection of fragrances for several online retailers, shipping directly to their customers and billing the retailers. Five Star also manufactures, on behalf of Perfumania, the Jerome Privee product line, which includes bath and body products and which is sold exclusively in Perfumania's retail stores. All manufacturing operations of Parlux and Five Star are outsourced.

Our retail business is conducted through the following subsidiaries:

•Perfumania, a specialty retailer of fragrances and related products,

•Perfumania.com, an Internet retailer of fragrances and other specialty items, and

•SOW, which sells fragrances in retail stores on a consignment basis.

As of April 29, 2017, Perfumania operated a chain of 240 retail stores specializing in the sale of fragrances and related products at discounted prices up to 75% below the manufacturers’ suggested retail prices. Perfumania.com, our Company-owned website, offers a selection of our more popular products for sale online. SOW operates a national designer fragrance consignment program, with contractual relationships to sell products on a consignment basis in approximately 1,100 stores, including approximately 600 Kmart locations nationwide. Its other retail customers include Bealls, K & G and Steinmart.

Certain reclassifications were made to prior year amounts to conform to the classifications of such amounts for the thirteen-weeks ended April 29, 2017.

NOTE 2 - RECENT ACCOUNTING PRONOUNCEMENTS

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330). The amendments, which apply to inventory that is measured using any method other than the last-in, first-out (LIFO) or retail inventory method, require that entities measure inventory at the lower of cost or net realizable value. ASU 2015-11 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016 and should be applied on a prospective basis. The Company adopted ASU No. 2015-11 prospectively effective January 29, 2017. There was no impact to the Company's consolidated financial statements.

7

NOTE 3 - ALLOWANCE FOR DOUBTFUL ACCOUNTS

The Company's accounts receivable consist primarily of trade receivables due from wholesale customers. In May 2016, a Panama based customer of Parlux that distributes in certain Latin American countries was placed on the Specially Designated Nationals list by the Office of Foreign Assets Control of the U.S. Treasury Department. As a result, the customer's assets have been frozen and any dealings between U.S. companies, including Parlux, and the customer have been prohibited. Accordingly, during the thirteen weeks ended April 30, 2016, management reserved the outstanding accounts receivable balance from the customer of approximately $1.7 million due to the uncertainty of future collection of these receivables.

NOTE 4 - GOODWILL AND INTANGIBLE ASSETS

Goodwill in the amount of $38.8 million at April 29, 2017 and January 28, 2017 resulted from the April 18, 2012 acquisition of Parlux.

The following table provides information related to goodwill and intangible assets (in thousands). Intangible assets are included in intangible and other assets, net on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017:

		April 29, 2017						January 28, 2017
	Useful Life (years)	Original Cost		Accumulated Amortization		Net Book Value		Original Cost		Accumulated Amortization		Net Book Value
Goodwill	N/A	$	38,769	$	—	$	38,769	$	38,769	$	—	$	38,769
Tradenames	4-20	9,357		8,181		1,176		9,357		8,084		1,273
Customer relationships	10	5,171		2,629		2,542		5,171		2,500		2,671
Favorable leases	7	886		886		—		886		886		—
License agreements	3-5	16,313		15,779		534		16,313		15,643		670
Tradename (non-amortizing)	N/A	7,180		—		7,180		7,180		—		7,180
		$	77,676	$	27,475	$	50,201	$	77,676	$	27,113	$	50,563

In accordance with US GAAP, goodwill and intangible assets with indefinite lives are not amortized, but rather tested for impairment at least annually by comparing the estimated fair values to their carrying values.

Trademarks, including tradenames and owned licenses having finite lives, are amortized over their respective lives to their estimated residual values and are also reviewed for impairment in accordance with accounting standards when changes in circumstances indicate the assets’ values may be impaired. Customer relationships are amortized over the expected period of benefit and license agreements are amortized over the remaining contractual term. Impairment testing is based on a review of forecasted operating cash flows and the profitability of the related brand to determine its fair value. There were no triggering events during the thirteen weeks ended April 29, 2017 that would indicate potential impairment and the requirement to review the carrying value of goodwill and intangible assets.

Amortization expense associated with intangible assets subject to amortization is included in depreciation and amortization on the accompanying condensed consolidated statements of operations. Amortization expense for intangible assets subject to amortization was $0.4 million and $0.9 million during the thirteen-weeks ended April 29, 2017 and April 30, 2016, respectively. As of April 29, 2017, estimated future amortization expense associated with intangible assets subject to amortization is as follows (in thousands):

Fiscal Year	Amortization Expense
Remainder of 2017	$	1,065
2018	877
2019	709
2020	684
2021	682
2022	235
	$	4,252

8

NOTE 5 - ACCOUNTING FOR SHARE-BASED PAYMENTS

The 2010 Equity Incentive Plan (the “2010 Plan”) provides for equity-based awards to the Company’s employees, directors and consultants. Under the 2010 Plan, the Company initially reserved 1,000,000 shares of common stock for issuance. This number automatically increases on the first trading day of each fiscal year beginning with fiscal 2011, by an amount equal to 1.5% of the shares of common stock outstanding as of the last trading day of the immediately preceding fiscal year; accordingly, 2,426,711 shares of common stock were reserved for issuance as of April 29, 2017. The Company previously had two stock option plans which expired on October 31, 2010. No further awards will be granted under these plans, although all options previously granted and outstanding will remain outstanding until they are either exercised or forfeited. As of April 29, 2017, 1,059,252 stock options have been granted pursuant to the 2010 Plan.

The following is a summary of the stock option activity during the thirteen weeks ended April 29, 2017:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 28, 2017	1,184,000		$	6.07
Granted	—		—
Exercised	—		—
Forfeited	(100,000	)	7.70
Outstanding as of April 29, 2017	1,084,000		$	5.92	6.9	$	—
Vested and expected to vest as of April 29, 2017	709,834		$	7.79	6.9	$	—
Exercisable as of April 29, 2017	709,834		$	7.79	6.9	$	—

The following is a summary of stock warrants activity during the thirteen weeks ended April 29, 2017:

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 28, 2017	6,299,971		$	11.80
Granted	—		—
Exercised	—		—
Forfeited	(2,133,332	)	8.00
Outstanding as of April 29, 2017	4,166,639		$	13.74	1.8	$	—
Vested and expected to vest as of April 29, 2017	4,166,639		$	13.74	1.8	$	—
Exercisable as of April 29, 2017	4,166,639		$	13.74	1.8	$	—

Share-based compensation expense was less than $0.1 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016.

9

NOTE 6 - REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES

The Company’s revolving credit facility and notes payable to affiliates consist of the following:

	April 29, 2017		January 28, 2017
	(in thousands)
Revolving credit facility, interest payable monthly, secured by a pledge of substantially all of the Company's assets	$	4,517	$	—
Subordinated notes payable-affiliates	125,366		125,366
	129,883		125,366
Less current portion	—		—
Total long-term debt	$	129,883	$	125,366

The Company has a revolving Senior Credit Facility with a syndicate of banks that is used for the Company’s general corporate purposes including working capital and capital expenditures. The maximum borrowing amount under the Senior Credit Facility is $175 million and the termination date is April 2019. Under this facility, which does not require amortization of principal, revolving loans may be drawn, repaid and reborrowed up to the amount available under a borrowing base calculated with reference to specified percentages of the Company’s credit card and trade receivables and inventory, which may be reduced by the lender in its reasonable discretion. The Company mustmaintain excess availability under the facility of at least$10 million. As ofApril 29, 2017, the Company had$80.1 millionof net availability which includes $25 million for letters of credit.

Interest under the Senior Credit Facility is at variable rates plus specified margins that are determined based upon the Company’s excess availability from time to time. The Company is also required to pay monthly commitment fees based on the unused amount of the Senior Credit Facility and a monthly fee with respect to outstanding letters of credit. As of April 29, 2017, the interest rate on outstanding borrowings was 5.0%.

All obligations of the Company related to the Senior Credit Facility are secured by first priority perfected security interests in all personal and real property owned by the Company, including without limitation 100% (or, in the case of excluded foreign subsidiaries, 66%) of the outstanding equity interests in the subsidiaries. The Company is subject to customary limitations on its ability to, among other things, pay dividends and make distributions, make investments and enter into joint ventures, and dispose of assets. The Company was in compliance with all financial and operating covenants as of April 29, 2017.

In addition, the Company has outstanding unsecured debt obligations to affiliates as follows:

(i)a promissory note in the principal amount of $35 million, (the “QKD Note”) held by Quality King Distributors, Inc. ("Quality King"), which provides for payment of principal in quarterly installments between July 31, 2019 and October 31, 2022, with a final installment on October 31, 2022 of the remaining balance, and payment of interest in quarterly installments commencing on January 31, 2011 at the then current senior debt rate, as defined in the Senior Credit Facility, plus 1% per annum;

(ii)promissory notes in the aggregate principal amount of approximately $85.4 million held by six estate trusts established by Glenn, Stephen and Arlene Nussdorf (the “Nussdorf Trust Notes”), which provide for payment of the principal in full on July 31, 2019 and payments of interest in quarterly installments commencing on July 31, 2012 at the then current senior debt rate plus 2% per annum; and

(iii)    a promissory note in the principal amount of $5 million held by Glenn and Stephen Nussdorf (the “2004 Note”), which provided for payment in January 2009 and is currently in default because of the restrictions on payment described below, resulting in an increase of 2% in the nominal interest rate, which is the prime rate plus 1%.

10

These notes are subordinated to the Senior Credit Facility. No principal may be paid on any of them until three months after the Senior Credit Facility terminates and is paid in full, and payment of interest is subject to satisfaction of certain conditions, including the Company’s maintaining excess availability under the Senior Credit Facility of the greater of $17.5 million or 17.5% of the borrowing base certificate after giving effect to the payment, and a fixed charge coverage ratio, as defined in the credit agreement, of 1.1:1.0. Interest expense on these notes was approximately $2.1 million and $1.5 million for the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively, and is included in interest expense on the accompanying condensed consolidated statements of operations. No payments of principal or interest have been made on the QKD Note or the Nussdorf Trust Notes. On the 2004 Note, no payments of principal have been made and no interest payments have been made since October 2008. Accrued interest payable due at April 29, 2017 and January 28, 2017 on the Nussdorf Trust Notes, the QKD Note, and the 2004 Note was approximately $52.9 million and $50.8 million, respectively, and is included in other long-term liabilities on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017, respectively.

NOTE 7 - ACCOUNTING FOR INCOME TAXES

The Company conducts business throughout the United States, Puerto Rico and the United States Virgin Islands and, as a result, files income tax returns in the U.S. Federal and various state jurisdictions, Puerto Rico and the United States Virgin Islands. In the normal course of business, the Company is subject to examinations in these jurisdictions. With few exceptions, the Company is no longer subject to U.S. Federal, state, local or Puerto Rico income tax examinations for fiscal years prior to 2008. State and foreign income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any Federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

The Company continues to provide a full valuation allowance against its net deferred tax assets due to the uncertainty as to when and if business conditions will improve sufficiently to enable it to utilize its deferred tax assets. The Company did not record a Federal or state tax expense for the thirteen-week periods ended April 29, 2017 and April 30, 2016, since the Company had a cumulative operating loss for each thirteen-week period.

During the thirteen weeks ended April 29, 2017, there were no changes to the liability for income tax associated with uncertain tax positions. The Company accrues interest related to unrecognized tax benefits as well as any related penalties in the income tax provision in its condensed consolidated statements of operations, which is consistent with the recognition of these items in prior reporting periods. The accrual for interest and penalties related to uncertain tax positions as of April 29, 2017 and January 28, 2017 was not significant.

The Company does not anticipate any material adjustments relating to unrecognized tax benefits within the next twelve months; however, the ultimate outcome of tax matters is uncertain and unforeseen results can occur.

NOTE 8 - BASIC AND DILUTED NET LOSS PER COMMON SHARE

Basic net loss per common share has been computed by dividing net loss by the weighted average number of common shares outstanding during the period.

Diluted net loss per common share includes, in periods in which they are dilutive, the effect of those potentially dilutive securities where the average market price of the common stock exceeds the exercise prices for the respective periods.

During the thirteen-week periods ended April 29, 2017 and April 30, 2016 there were 5,250,639 and 7,135,556, respectively, potential shares of common stock which were excluded from the diluted loss per share calculation because the effect of including these potential shares would have been antidilutive.

NOTE 9 - FAIR VALUE MEASUREMENTS

The Company applies authoritative accounting guidance regarding fair value and disclosures as it applies to financial and non-financial assets and liabilities. The guidance defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows:

Level 1: Observable inputs such as quoted prices in active markets (the fair value hierarchy gives the highest priority to

Level 1 inputs);

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

11

Level 3: Unobservable inputs in which there is little or no market data and require the reporting entity to develop its own assumptions.

As of April 29, 2017, the Company had no material financial assets or liabilities measured on a recurring basis at fair value. The Company measures certain assets at fair value on a non-recurring basis, specifically long-lived assets evaluated for impairment. No such impairments were recorded during the thirteen-week periods ended April 29, 2017 and April 30, 2016.

The fair values of the Company’s assets and liabilities that qualify as financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and short-term debt are carried at cost, which approximates fair value due to the short-term maturity of these instruments. The reported amounts of long-term obligations approximate fair value, given management’s evaluation of the instruments’ current rates compared to market rates of interest and other factors.

NOTE 10 - CONTINGENCIES

On February 21, 2017, Kiss Nail Products, Inc. (Plaintiff) sued Parlux and Roraj Trade, LLC (the licensor of Rihanna’s intellectual property), ("Defendants"), in the U.S. District Court for the Southern District of New York alleging both federal and state law trademark infringement and unfair competition arising out of Parlux’s sale and distribution of the “Kiss by Rihanna” fragrance. Plaintiff alleges that such sale and distribution infringes its “Kiss” mark on nail care and other beauty products. Plaintiff seeks, inter alia, to enjoin Defendants’ distribution and sales of the alleged offending products and seeks unspecified money damages as well as treble damages, attorneys’ fees, punitive damages and interest. Pursuant to an agreement between Parlux and Roraj, Parlux has agreed to defend and indemnify Roraj in this case. On April 19, 2017, the Defendants filed an Answer in the nature of a general denial along with Counterclaims seeking a declaratory judgment that Plaintiff has abandoned the mark with regard to perfume, fragrance, cologne and related fragrance products. Defendants are also seeking a declaration that they have not infringed any of Plaintiff’s marks. The Court has set a schedule which calls for the conclusion of fact and expert discovery on or about December 20, 2017, with dispositive motion practice likely to follow. The Court has also referred the case to a Magistrate Judge for a settlement conference.

In August 2015, the Company was named as a defendant in a class action filed in the Superior Court for the State of California, County of Ventura. The plaintiff, a former employee of Perfumania, sought to represent all current and former sales associates at California Perfumania stores. The complaint alleged various violations of California law related to wages, meal periods and wage statements, among other things. In October 2016, the parties agreed in principle on a settlement which has been submitted to the Court. The settlement proceeds will be deposited with the settlement administrator when the court provides its final approval, which is expected sometime in 2017. The Company accrued the estimated settlement of approximately $0.5 million during the thirteen weeks ended October 29, 2016.

In November 2015, the Company was named as a defendant in a putative class action in the U.S. District Court for the Southern District of Alabama. The complaint, and thereafter an amended complaint, alleged that the Company violated the Telephone Consumer Protection Act ("TCPA") by sending unsolicited facsimiles which advertised goods and/or services offered by the Company. The plaintiff sought to represent a nationwide class of all recipients of such unsolicited faxes for the period November 3, 2011 to the present. Plaintiff sought statutory damages of at least $500 per violative fax, plus other non-monetary relief. The parties agreed to mediate the matter, which resulted in a settlement in principle. A formal settlement agreement, on a class wide basis, was entered into in late November 2016. Defendants will obtain a release, on a class wide basis, from all members of the settlement class who do not opt out, back to January 2011. The settlement has been preliminarily approved by the Court and notice has been disseminated to potential class members, who had the opportunity to opt out of the class or to object to the settlement on or before March 31, 2017. No objections have been received, but there have been four opt-outs and various claims. The settlement will be presented to the Court for final approval at a hearing currently scheduled for June 29, 2017. Assuming final approval, claims will be submitted, reviewed, and paid as appropriate. It is expected that this process will be concluded during calendar 2017. The Company accrued the estimated settlement of approximately $0.5 million during the thirteen weeks ended October 29, 2016.

The Company is involved in various legal proceedings in the ordinary course of business. Management cannot presently predict the outcome of these matters, although management believes, based in part on the advice of counsel, that the ultimate resolution of these matters will not have a materially adverse effect on the Company's consolidated financial position, results of operations or cash flows. See also the discussion of litigation with licensor in Note 11 of this Form 10-Q.

NOTE 11 - RELATED-PARTY TRANSACTIONS

Glenn, Stephen and Arlene Nussdorf owned an aggregate 7,742,282 shares or approximately 50.0% of the total number of shares of the Company’s outstanding common stock as of April 29, 2017, excluding shares issuable upon exercise of certain warrants and not assuming the exercise of any outstanding options. Stephen Nussdorf has served as the Chairman of the

12

Company’s Board of Directors since February 2004 and Executive Chairman of the Board since April 2011. Glenn Nussdorf is a director of subsidiaries of the Company.

The Nussdorfs are officers and principals of Quality King, which distributes pharmaceuticals and health and beauty care products, and the Company’s President and Chief Executive Officer, Michael W. Katz, is also an executive of Quality King.

See Note 6 for a discussion of notes payable to affiliates.

Transactions With Affiliated Companies

Glenn Nussdorf has an ownership interest in Lighthouse Beauty Marketing, LLC, Lighthouse Beauty, LLC and Lighthouse Beauty KLO, LLC (collectively the "Lighthouse Companies"), all of which are manufacturers and distributors of prestige fragrances and have been suppliers to the Company.

The Company purchases merchandise from Jacavi Beauty Supply, LLC (“Jacavi”), a fragrance distributor. Jacavi's managing member is Rene Garcia. Rene Garcia, his family trusts and related entities are members of a group (the "Garcia Group") that owned an aggregate 2,211,269 shares, or approximately 14.3%, of the total number of shares of the Company's outstanding common stock as of April 29, 2017, excluding shares issuable upon exercise of certain warrants. See disclosures of merchandise purchases in the table below.

The Company sells merchandise to Reba Americas LLC ("Reba"), which distributes fragrances primarily in Puerto Rico and the Caribbean. Family trusts of Rene Garcia own 50% of Reba. Net sales to Reba were approximately $1.1 million and $0.7 million during the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively. The balance due from Reba as of April 29, 2017 and January 28, 2017 was approximately $0.6 million and $0.4 million, respectively, and is included in accounts receivable, net of allowances, on the accompanying condensed consolidated balance sheets. The Company also purchased certain merchandise from Reba during the thirteen-week periods ended April 29, 2017 and April 30, 2016.

The amounts due to these related companies are non-interest bearing and are included in accounts payable-affiliates in the accompanying condensed consolidated balance sheets. Transactions for merchandise purchases with these related companies during the thirteen-week periods ended April 29, 2017 and April 30, 2016 were as follows (in thousands):

	Total Purchases Thirteen Weeks Ended April 29, 2017		Total Purchases Thirteen Weeks Ended April 30, 2016		Balance Due April 29, 2017		Balance Due January 28, 2017
Lighthouse Companies	$	—	$	—	$	90	$	90
Jacavi	311		1,449		—		590
Quality King	—		13		—		—
Reba	—		122		357		337
	$	311	$	1,584	$	447	$	1,017

Glenn, Stephen and Arlene Nussdorf own GSN Trucking, Inc. (“GSN”) which provides general transportation and freight services. The Company periodically utilizes GSN to transport both inbound purchases of merchandise and outbound shipments to wholesale customers. There were no payments to GSN during the thirteen weeks ended April 29, 2017. During the thirteen weeks ended April 30, 2016, total payments to GSN for transportation services provided were less than $0.1 million. There was no balance due to GSN at April 29, 2017 or January 28, 2017.

Quality King leases a 560,000 square foot facility in Bellport, NY. The Company began occupying approximately half of this facility in December 2007 under a sublease that terminates on September 30, 2027 and this location serves as the Company’s principal offices. As of April 29, 2017, the monthly current sublease payments are approximately $240,000 and increase by 3% annually. Total payments by the Company to Quality King for this sublease were approximately $0.7 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively.

The Company and Quality King are parties to a Services Agreement providing for the Company’s participation in certain third party arrangements at the Company’s respective share of Quality King’s cost, including allocated overhead, plus a 2% administrative fee, and the provision of legal services. The Company also shares with Quality King the economic benefit of the bulk rate contract that the Company has with UPS to ship Quality King’s merchandise and related items. The Services Agreement will terminate on thirty days’ written notice from either party. The expenses charged under these arrangements to the Company were $0.2 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016. The balance

13

due to Quality King for expenses charged under the Services Agreement was $0.1 million and less than $0.1 million at April 29, 2017 and January 28, 2017, respectively.

On April 18, 2012, Parlux, Artistic Brands Development LLC (“Artistic Brands”) (a company controlled by Rene Garcia), Shawn C. Carter (who is the beneficial owner of 10% of the Company’s common stock) and S. Carter Enterprises, LLC entered into a sublicense agreement and Artistic Brands, Shawn Carter and S. Carter Enterprises, LLC entered into a license agreement. In connection with these agreements, the Company issued to Artistic Brands and its designees, including Shawn Carter, warrants for the purchase of an aggregate of 1,599,999 shares of the Company's common stock at an exercise price of $8.00 per share. Pursuant to the license agreement, Artistic Brands obtained the exclusive right and license to manufacture, promote, distribute, and sell prestige fragrances and related products under the Jay-Z trademark. The initial term of the license agreement expires at the earlier of (i) five years following the first date on which licensed products are shipped and (ii) December 31, 2018. Artistic Brands has the right to renew the license agreement, so long as certain financial conditions are met and it has not otherwise breached the agreement. Pursuant to the license agreement, Artistic Brands agreed to make certain royalty payments, including certain guaranteed minimum royalties. Pursuant to the sublicense agreement, Artistic Brands sublicensed all rights granted under the license agreement to the Company, and in return the Company assumed all of Artistic Brands' obligations under the license agreement, including making all royalty payments and certain guaranteed minimum royalties owed to S. Carter Enterprises, LLC. No royalties have been paid during the thirteen weeks ended April 29, 2017 or April 30, 2016.

On January 25, 2016, the Company and Parlux filed a lawsuit against S. Carter Enterprises, LLC and Shawn C. Carter in the Supreme Court of the State of New York, County of New York. In general, the lawsuit alleges that the defendants have breached the license described above and related agreements by not acting timely or in good faith in approving products and launches under the license and not supporting the brand via personal appearances as required by the license. The lawsuit seeks a determination that such breaches undermine the essence of the license thereby warranting rescission of the license, return of the consideration paid on account of the license and related agreements, monetary damages, and other relief. On May 6, 2016, the defendants filed an answer in the nature of a general denial, with a counterclaim for, inter alia, amounts allegedly due to them under the license agreements in the amount of approximately $2.7 million. The Company has filed a reply to that counterclaim in the nature of a general denial. The Court has set a schedule which calls for the conclusion of fact and expert discovery by January 2018, with dispositive motion practice to follow. On May 5, 2017, the defendants filed a motion for partial summary judgment on their counterclaim. The Company submitted opposition papers on June 9, 2017, and defendants have until June 30 to submit reply papers. Thereafter, the motion will be presented to the Court on July 5, 2017.

The Company has announced that a special committee of our independent directors is considering various alternatives to address the Company’s financial condition. The special committee is considering the Company’s capital structure and possible alternatives that could result in value to all shareholders, and has contacted members of the Nussdorf family, our principal shareholders, to begin discussions over possible approaches. The Company does not have a defined timeline for the strategic review process, and there can be no assurance that it will result in any strategic alternative being announced or consummated.

NOTE 12 - SEGMENT INFORMATION

The Company operates in two industry segments, wholesale distribution and specialty retail sales of designer fragrance and related products. Management reviews segment information by segment and on a consolidated basis each month. Retail sales include sales through Perfumania retail stores, the SOW consignment business and the Company’s internet site, Perfumania.com. Wholesale sales include sales through QFG, Parlux and Five Star to unrelated customers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in the Annual Report on Form 10-K for the fiscal year ended January 28, 2017. The Company’s chief operating decision maker, who is its Chief Executive Officer, assesses segment performance by reference to gross profit. Each of the segments has its own assets, liabilities, revenues and cost of goods sold. While each segment has certain unallocated operating expenses, these expenses are not reviewed by the chief operating decision maker on a segment basis, but rather on a consolidated basis. Financial information for these segments is summarized in the following table:

14

	Thirteen Weeks Ended April 29, 2017			Thirteen Weeks Ended April 30, 2016
	(in thousands)
Net sales:
Wholesale	$	51,102		$	53,464
Retail	46,794			51,675
	$	97,896		$	105,139
Gross profit:
Wholesale	$	22,833		$	25,440
Retail	22,136			26,329
	$	44,969		$	51,769
	April 29, 2017			January 28, 2017
Total assets:
Wholesale	$	699,812		$	681,055
Retail	368,466			364,117
	1,068,278			1,045,172
Eliminations (a)	(763,539		)	(732,372		)
Consolidated assets	$	304,739		$	312,800

(a) Adjustment to eliminate intercompany receivables and investment in subsidiaries

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

ThisForm 10-Q, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by words or phrases such as “may,” “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target,” “forecast,” “objective,” “assume,” “strategies” and other words and terms of similar meaning. Forward-looking statements involve estimates, expectations, projections, goals, forecasts, assumptions, risks and uncertainties. We caution readers that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement.

Among the factors that could cause actual results, performance or achievement to differ materially from those described or implied in the forward-looking statements are our ability to service our obligations, our ability to comply with the covenants in our Senior Credit Facility, any deterioration of general economic conditions and weaker discretionary spending by consumers, due to various factors including the diminishing patronage by retail customers at malls where our stores are located and other factors included in our filings with the SEC. Copies of our SEC filings are available from the SEC or may be obtained upon request from us.

You should also consider carefully the statements under “Risk Factors” in our Form 10-K which address additional factors that could cause our actual results to differ from those set forth in the forward-looking statements and could materially and adversely affect our business, operating results and financial condition. We cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

We are an independent, national, vertically integrated wholesale distributor and specialty retailer of designer perfumes and fragrances. We source the majority of these products directly from the brand owners/manufacturers. We also own and license certain designer and other fragrance brands that we manufacture, through subcontractors, and sell through our wholesale and retail operating subsidiaries.

15

Net sales during the thirteen weeks ended April 29, 2017, our first quarter in fiscal 2017, decreased 6.9% compared to the first quarter of fiscal 2016. Our wholesale segment’s net sales decreased by 4.4% from the thirteen weeks ended April 30, 2016. During the year, wholesale sales fluctuate due to seasonal demand, new product launches, the size and timing of certain orders from our customers, additions or losses of brand distribution rights, changes in foreign exchange rates against the U.S. dollar and the timing of industry trade shows and, accordingly, sales and results of operations can vary significantly from quarter to quarter. Our retail segment’s net sales decreased by 9.4% from the thirteen weeks ended April 30, 2016 because of fewer Perfumania stores and lower comparable store sales compared with last year’s first quarter and the transition of SOW's former largest consignment account to a wholesale customer.

Gross profit during the thirteen weeks ended April 29, 2017 was $45.0 million, a decrease of 13.1% from the thirteen weeks ended April 30, 2016 . The decrease in gross profit was due to lower retail and wholesale net sales.

Total operating expenses were $52.5 million during the thirteen weeks ended April 29, 2017, a decrease of 7.0% compared to the thirteen weeks ended April 30, 2016. The decrease was attributable to lower Perfumania store occupancy costs, commissions, advertising and sales promotion expense and provision for bad debts.

Interest expense was $2.1 million and $1.7 million during the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively.

We did not record a tax provision during the thirteen-week periods ended April 29, 2017 and April 30, 2016 since we have operating losses for those periods. We record a full valuation allowance against all deferred tax assets, thus no income tax benefit was recorded during the thirteen-week periods ended April 29, 2017 and April 30, 2016.

As a result of the above, our net loss increased by 50.6% to $9.7 million during the first quarter of fiscal 2017 from $6.4 million during last year’s first quarter.

With the rapidly increasing shift in consumer shopping patterns out of traditional retail to e-commerce, management is reviewing and updating the Company’s sales strategy, including our business model and cost structure, to identify initiatives to reduce and align our overhead structure with our current business model, improve supply chain efficiency, optimize marketing spending, reduce expenses and improve operating results in the long-term.

Comparison of the Thirteen Weeks Ended April 29, 2017 with the Thirteen Weeks Ended April 30, 2016.

Net Sales

	Thirteen Weeks Ended April 29, 2017		Percentage of Net Sales	Thirteen Weeks Ended April 30, 2016		Percentage of Net Sales	Dollar Change
	($ in thousands)
Wholesale	$	51,102	52.2%	$	53,464	50.9%	$	(2,362	)
Retail	46,794		47.8%	51,675		49.1%	(4,881		)
Total net sales	$	97,896	100%	$	105,139	100%	$	(7,243	)

Net sales decreased 6.9% from $105.1 million in the thirteen weeks ended April 30, 2016 to $97.9 million in the thirteen weeks ended April 29, 2017. The decrease in sales included a $2.3 million decrease in wholesale sales and a $4.9 million decrease in retail sales.

Wholesale sales decreased by 4.4% from $53.4 million in the thirteen weeks ended April 30, 2016 to $51.1 million in the thirteen weeks ended April 29, 2017 due to lower demand by Parlux's customers. QFG's sales increased from $34.0 million in the thirteen weeks ended April 30, 2016 to $34.3 million in the thirteen weeks ended April 29, 2017. Parlux's sales decreased from $19.1 million in the thirteen weeks ended April 30, 2016 to $16.7 million in the thirteen weeks ended April 29, 2017 due to lower demand by United States department store customers.

Retail sales decreased by 9.4% from $51.7 million in the thirteen weeks ended April 30, 2016 to $46.8 million in the thirteen weeks ended April 29, 2017. Perfumania's retail sales decreased by $3.5 million and SOW's consignment sales decreased by $1.4 million.

Perfumania's retail sales decreased from $45.2 million in the thirteen weeks ended April 30, 2016 to $41.7 million in the thirteen weeks ended April 29, 2017. The decrease in Perfumania's sales was due primarily to fewer stores being operated. The average number of stores operated was 250 in the thirteen weeks ended April 29, 2017 and 306 in the thirteen weeks ended April 30, 2016. The reduction in store count is due to the closure of under-performing stores over the past eighteen months. Perfumania's comparable store sales decreased by 2.1% during the thirteen weeks ended April 29, 2017 from the same period in 2016 due to

16

lower mall traffic. Comparable store sales measure sales from stores that have been open for one year or more. We exclude stores that are closed for renovation from comparable store sales from the month during which renovation commences until the first full month after reopening. The average retail price per unit sold during the thirteen weeks ended April 29, 2017 decreased by 9% from the prior year's comparable period due to more promotional pricing, while the total number of units sold increased by 1%.

We are focused on carefully managing and reducing Perfumania's physical retail store portfolio. We intend to strictly limit the number of new Perfumania store openings for the foreseeable future, and will focus on maximizing sales and store productivity and controlling expenses at existing stores. We are also accelerating the closure of under-performing stores and stores where we anticipate declining mall traffic and do not see the potential for long-term growth and profitability by exercising lease termination options included in certain store leases, choosing not to renew/extend leases on maturing leases and negotiating early lease terminations with landlords. We closed 47 stores during the thirteen weeks ended April 29, 2017.

SOW's consignment sales decreased from $6.5 million in the thirteen weeks ended April 30, 2016 to $5.1 million in the thirteen weeks ended April 29, 2017. The decrease in SOW's net sales is due to a decrease in sales of approximately $1.6 million during the thirteen weeks ended April 29, 2017 by Burlington Coat Factory ("Burlington"), formerly SOW's largest consignment account, which has been transitioned to be a wholesale customer of QFG. During the thirteen weeks ended April 29, 2017, sales by QFG to Burlington were approximately $2.3 million compared with $2.1 million during the comparable period in fiscal 2016.

Gross Profit

	Thirteen Weeks Ended April 29, 2017		Thirteen Weeks Ended April 30, 2016		Dollar Change
	($ in thousands)
Wholesale	$	22,833	$	25,440	$	(2,607	)
Retail	22,136		26,329		(4,193		)
Total gross profit	$	44,969	$	51,769	$	(6,800	)

Gross Profit Percentages

	Thirteen Weeks Ended April 29, 2017	Thirteen Weeks Ended April 30, 2016
Wholesale	44.7%	47.6%
Retail	47.3%	51.0%
Total gross profit percentage	45.9%	49.2%

Gross profit decreased 13.1% from $51.8 million in the thirteen weeks ended April 30, 2016 to $45.0 million in the thirteen weeks ended April 29, 2017.

QFG's gross profit dollars was $14.7 million during both thirteen-week periods ended April 30, 2016 and April 29, 2017. Parlux's gross profit dollars decreased from $10.8 million during the thirteen weeks ended April 30, 2016 to $8.1 million during the thirteen weeks ended April 29, 2017 due to lower net sales. Wholesale gross profit percentage decreased from 47.6% during the thirteen weeks ended April 30, 2016 to 44.7% during the thirteen weeks ended April 29, 2017.

Perfumania's retail gross profit dollars decreased from $22.3 million during the thirteen weeks ended April 30, 2016 to $18.7 million during the thirteen weeks ended April 29, 2017 due to lower net sales discussed above. For these same periods, Perfumania's retail gross margins were 49.4% and 44.8%, respectively. The decrease in gross margins is due to more promotional pricing at Perfumania stores.

SOW's gross profit dollars decreased from $4.0 million during the thirteen weeks ended April 30, 2016 to $3.4 million during the thirteen weeks ended April 29, 2017 primarily due to lower sales by SOW discussed above. For these same periods, SOW's gross margins were 68.0% and 62.0%, respectively.

Expenses

Selling, general and administrative expenses include payroll and related benefits for our distribution centers, sales, store operations, field management, purchasing and other corporate office and administrative personnel; rent, common area maintenance, real estate taxes and utilities for our stores, distribution centers and corporate office; advertising, consignment fees, sales promotion,

17

royalties, insurance, supplies, freight out, certain costs related to the implementation of a new computer system and other administrative expenses. Selling, general and administrative expenses were $50.9 million in the thirteen weeks ended April 29, 2017, compared to $53.9 million in the thirteen weeks ended April 30, 2016. The decrease in selling, general and administrative expenses is attributable to lower Perfumania store occupancy costs due to the reduction in Perfumania's store count, lower sales commissions on consignment sales due to lower sales by SOW as discussed above, lower advertising expenses and lower bad debt expense offset by an increase in professional fees resulting from our review of the Company's business model described below. Included in selling, general and administrative expenses are expenses in connection with the Services Agreement with Quality King, which were $0.2 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016.

Depreciation and amortization was approximately $1.5 million and $2.5 million in the thirteen-weeks periods ended April 29, 2017 and April 30, 2016, respectively.

Share-based compensation expense of less than $0.1 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016 represents the expense incurred on outstanding stock options.

Interest expense was approximately $2.1 million and $1.7 million for the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively. The increase in interest expense is due to a higher average interest rate on notes payable to affiliates.

The Company did not record a tax provision during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016 since the Company has cumulative pre-tax losses for the thirteen week periods.

As a result of the foregoing, we incurred net loss of approximately $9.7 million in the thirteen-week period ended April 29, 2017 compared to net loss of $6.4 million in the thirteen weeks ended April 30, 2016.

The customer trends affecting our recent performance are likely to continue to exert downward pressure on our revenues. We are reviewing and updating the Company’s sales strategy, including our business model and cost structure, to identify initiatives to reduce and align our overhead structure with our current business model, improve supply chain efficiency, optimize marketing spending, reduce expenses and improve operating results in the long-term. Among other strategies, we are accelerating closings of under-performing stores and working to increase e-commerce sales. We believe we can significantly increase our e-commerce penetration and establish the framework of a successful long-term e-commerce strategy. As customers increasingly shop across multiple channels, we continue to invest in these and other omni-channel initiatives in order to create a more seamless shopping experience for our customers. These strategic changes may have a material impact on our expenses in the nearer term but are intended to increase revenues. In addition, any changes, including changes to our capital structure, resulting from the independent directors’ review of our financial condition described below in “Liquidity and Capital Resources” may also have a material impact on our results of operations.

LIQUIDITY AND CAPITAL RESOURCES

Net cash used in operating activities during the thirteen weeks ended April 29, 2017 was approximately $9.5 million, compared with approximately $0.7 million used in operating activities during the thirteen weeks ended April 30, 2016. This increase in cash used in operations results from the increase in our net loss and changes in our working capital. The seasonality of our operations may lead to significant fluctuations in certain asset and liability accounts between fiscal year-end and subsequent interim periods.

Net cash used in investing activities was approximately $0.3 million in the thirteen weeks ended April 29, 2017 compared to $0.8 million in the thirteen weeks ended April 30, 2016. Investing activities during the thirteen weeks ended April 29, 2017 consisted of corporate and information technology enhancements. The decrease in cash used in investing activities resulted from less information technology spending during the thirteen weeks ended April 29, 2017 versus last year's comparative period and no new Perfumania store openings during the thirteen weeks ended April 29, 2017 compared with the thirteen weeks ended April 30, 2016. During the thirteen weeks ended April 29, 2017, Perfumania did not open any new stores and closed 47 stores compared with one new store and 11 store closures during the thirteen weeks ended April 30, 2016. We plan to open one store and continue to close under-performing stores during the remainder of fiscal 2017. We continue to evaluate the need to close, remodel or relocate existing stores.

Net cash provided by financing activities during the thirteen weeks ended April 29, 2017 was approximately $4.2 million, compared with $1.3 million used in financing activities for the thirteen weeks ended April 30, 2016. The $5.5 million increase in cash provided by financing activities is due primarily to higher borrowings under our bank line of credit. Our borrowings under our line of credit increased due to the increase in our net loss and the timing of payments to trade vendors during the thirteen weeks ended April 29, 2017 compared with the thirteen weeks ended April 30, 2016.

The Company has a $175 million revolving credit facility with a syndicate of banks (the “Senior Credit Facility”), which is used for the Company's general corporate purposes and those of its subsidiaries, including working capital. The Company and certain of its subsidiaries are co-borrowers under the Senior Credit Facility, and the Company’s other subsidiaries have guaranteed all of their obligations thereunder. The Company was in compliance with all financial and operating covenants

18

under the Senior Credit facility as of April 29, 2017. As of April 29, 2017, the Company had $80.1 million available to borrow under the Senior Credit Facility which includes $25 million for letters of credit, based on the borrowing base at that date.

The Company has various unsecured notes payable outstanding to affiliates which in aggregate total $125.4 million of principal. No payments of principal may be made on any of these notes payable to affiliates before the maturity of the Senior Credit Facility although interest payments are permitted under certain conditions. See further discussion of our notes payable to affiliates and our Senior Credit Facility in Note 6 of our condensed consolidated financial statements included in this Form 10-Q.

Our liquidity is impacted by a number of factors, including our sales levels, the amount of credit that our vendors extend to us and our borrowing capacity under our Senior Credit Facility. Our principal funding requirements are for inventory purchases, financing extended terms on accounts receivable, paying down accounts payable and debt, information system enhancements, and to a lesser extent, opening new stores and renovation of existing stores. These capital requirements generally have been satisfied through borrowings under the Senior Credit Facility and funds from operations. Based on current internal sales and cash flow projections, current vendor payable support and our projected available borrowing capacity under our Senior Credit Facility, as well as other initiatives to maximize cash flow, we believe that these resources will be adequate to meet our requirements in both the short and long-term.

In addition to the work on operational strategies described above, we have announced that a special committee of our independent directors is considering various alternatives to address the Company’s financial condition. The special committee is considering the Company’s capital structure and possible alternatives that could result in value to all shareholders, and has contacted members of the Nussdorf family, our principal shareholders, to begin discussions over possible approaches. The Company does not have a defined timeline for the strategic review process, and there can be no assurance that it will result in any strategic alternative being announced or consummated.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our condensed consolidated financial statements have been prepared in accordance with US GAAP. Preparation of these statements requires management to make judgments and estimates that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, management evaluates its estimates, including those related to bad debts, inventories, asset impairments, sales returns and allowances, income taxes and other contingent assets and liabilities. As such, some accounting policies have a significant impact on amounts reported in these financial statements. The judgments and estimates made can significantly affect results. Materially different amounts might be reported under different conditions or by using different assumptions. We consider an accounting policy to be critical if it is both important to the portrayal of our financial condition and results of operations, and requires significant judgment and estimates by management in its application. We have identified certain critical accounting policies that affect the significant estimates and judgments used in the preparation of its financial statements. There have been no significant changes to our critical accounting policies and estimates as discussed in our Annual Report on Form 10-K for the year ended January 28, 2017.

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable

ITEM 4. CONTROLS AND PROCEDURES

As of the end of the period covered by this report (April 29, 2017), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.

During the first quarter of fiscal 2017 there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

19

ITEM 1A. RISK FACTORS

The risk factors described in Item 1A to our Annual Report on Form 10-K for the year ended January 28, 2017 are supplemented with the following:

We are considering a restructuring of our operations and capital structure, which may have a material impact on our results of operations and on shareholders’ investments.

We have announced that we are reviewing and updating our operations, particularly including our retail businesses, with the goal of improving operating results in the long-term. Among other strategies, we are accelerating closings of under-performing stores and working to increase e-commerce sales. Any strategic changes resulting from this review may have a material impact on our results of operations.

We have also announced that a special committee of independent members of our Board of Directors has considered various alternatives to address our financial condition and capital structure and has contacted members of the Nussdorf family, our principal shareholders, to begin discussions over possible approaches that could result in value to all shareholders. No decision has been made by our Board, and there can be no assurance that any such alternatives would be undertaken. However, the result of this process may have a material impact on our capital structure and the shareholders’ investments.

We may be required to record impairments of long-lived assets relating to our retail operations.

Impairment testing of our retail stores' long-lived assets requires us to make estimates about our future performance and cash flows that are inherently uncertain. These estimates can be affected by numerous factors, including changes in economic conditions, our results of operations, and competitive conditions in the industry. During fiscal 2016, we recorded impairment charges related to our Perfumania retail stores of $5.6 million, and we also recorded an impairment charge of $1.3 million related to Perfumania's tradename. The failure of stores to achieve acceptable results and a restructuring of our operations and capital structure could result in additional store asset impairment charges and charges related to Perfumania's tradename in the future, which may have a material adverse impact on our business and financial results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

On March 27, 2017, the Company entered into Indemnification Agreements in the form filed as Exhibit 10.1 to this form 10-Q with each of its directors and executive officers.

20

ITEM 6. EXHIBITS

The exhibits listed in the following Exhibit Index are filed herewith.

3.1	Amended and Restated Articles of Incorporation, as amended through August 8, 2008 (Incorporated by reference to Exhibit 3.1 to the Company's Form 10-K filed July 2, 2009).
3.2	Articles of Amendment to Amended and Restated Articles of Incorporation, filed April 17, 2012 (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K filed April 19, 2012).
3.3	Bylaws (Incorporated by reference to Exhibit 3.2 to the Company's Registration Statement on Form S-1 (No 33-46833)).
10.1	Form of Indemnification Agreement dated March 27, 2017 between the Company and each of its directors and executive officers.
31.1	Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification by Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

21

PERFUMANIA HOLDINGS, INC. AND SUBSIDIARIES

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			PERFUMANIA HOLDINGS, INC. (Registrant)
Date:	June 19, 2017	By:	By: /s/ Michael W. Katz
			Michael W. Katz
			President and Chief Executive Officer
			(Principal Executive Officer)
		By:	By: /s/ Michael P. Nofi
			Michael P. Nofi
			Chief Financial Officer
			(Principal Financial and Accounting Officer)

22

EX-10.14

Exhibit 10.1

INDEMNIFICATION AGREEMENT

This Indemnification Agreement, effective as of March 27, 2017 (the “Effective Date”), is made by and between Perfumania Holdings, Inc., a Florida corporation (the “Company”), and _______, (the “Indemnitee”).

RECITALS

A.    The Company is aware that competent and experienced persons are increasingly reluctant to serve as directors of corporations, unless they are protected by comprehensive indemnification and liability insurance, because of increased exposure to litigation costs and risks resulting from their service to such corporations, and because the exposure frequently bears no reasonable relationship to the compensation of such directors.     

B.     Based upon their experience, the Board, as defined below, has concluded that in order to attract and retain talented and experienced individuals to serve as directors of the Company and its subsidiaries, it is necessary for the Company to contractually indemnify its directors, and to protect them against Expenses and damages in connection with certain claims against such directors.

C.     The Company desires and has requested the Indemnitee to serve or continue to serve in one or more capacities within the meaning of “Agent”, as defined below.

D.    The Indemnitee is willing to serve or continue serving the Company in one or more of such capacities provided that the Indemnitee is provided with the indemnity and liability insurance required in this Agreement.

E.        This Agreement supplements and adds to any protections provided by the Company’s articles of incorporation, bylaws and any resolutions adopted pursuant thereto, and shall not be deemed to diminish or abrogate any rights of the Indemnitee thereunder.     

AGREEMENT

NOW, THEREFORE, the parties hereto, intending to be legally bound, hereby agree as follows:

1. Definitions. The following definitions will apply for purposes of this Agreement:

“Agent” means any person who: (a) is or was a director, manager, officer, employee or agent of the Company or any Subsidiary; (b) is or was serving at the request of, for the convenience of or to represent the interest of the Company or any Subsidiary as a director, manager, officer, other fiduciary, employee or agent of another foreign or domestic corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other entity or enterprise; (c) was a director, manager, officer, employee or agent of any corporation, limited liability company, partnership, joint venture, trust or other entity or enterprise which was a predecessor to the Company or any Subsidiary; or (d) was a

director, manager, officer, employee or agent of another entity or enterprise at the request of, for the convenience of or to represent the interests of such predecessor entity or enterprise.

“Board” means the Company’s board of directors.

“Disinterested Director” means a director of the Company who is not and was not a party or threatened party to the Proceeding in respect of which indemnification or advancement of expenses is sought by the Indemnitee.

“Expenses” means all direct and indirect costs of any type or nature whatsoever (including, without limitation, all attorneys’ fees and related disbursements, and other out-of-pocket costs, such as, for example, those associated with time spent addressing, contesting, participating in, or responding to legal and regulatory matters or Proceedings in which the Indemnitee is not a party, such as subpoenas, testimony, bankruptcy filings or Proceedings, litigation, arbitration, government or industry regulatory inquiries, whether made at the Company’s request, the request of a third party or by subpoena or equivalent) actually and reasonably incurred by Indemnitee in connection with either the investigation, defense or appeal of a Proceeding or establishing or enforcing a right to indemnification or advancement of expenses under this Agreement or otherwise; provided, however, that the term “Expenses” shall not include any judgments, fines, ERISA excise taxes or penalties or amounts paid in settlement of a Proceeding.

“Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five (5) years has been, retained to represent: (a) the Company or the Indemnitee in any matter material to either such party; or (b) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or the Indemnitee in an action to determine the Indemnitee’s rights under this Agreement.

“Liabilities” means any type of liabilities whatsoever including, without limitation, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement of any Proceeding.

“Proceeding” means any threatened, pending or completed action, claim, suit or other proceeding, whether civil, criminal, administrative, investigative or any other type whatsoever.

“Subsidiary” means any corporation or other entity or enterprise as to which: (a) not less than 50% of the outstanding shares of stock or other ownership interests is owned directly or indirectly by the Company; or (b) the Company has control. For purposes of this definition, the term “control” means the Company’s power, whether directly or indirectly, to direct or cause the direction of the management or policies of such corporation or other entity or enterprise.

“Triggering Event” means:

(a) a change in control of the Company occurring after the Effective Date of a nature that would be required to be reported in response to Item 5.01 of Current Report on Form 8-K (or in response to any similar item on any similar schedule or form) promulgated under the Securities Exchange Act of 1934 (the “Act”), whether or not the Company is then subject to such reporting requirement; provided, however, that, without limiting the foregoing, a change in control shall be deemed to have occurred if, after the Effective Date, any “person” (as such term is used in Sections 13(d) and 14(d) of the Act) becomes the “beneficial owner” (as defined in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities without the prior approval of at least two-thirds of the members of the Board in office immediately prior to such person’s attaining of such percentage;

(b) a merger, consolidation, sale of assets or other transaction to which the Company is a party, or a proxy contest, as a consequence of which members of the Board in office immediately prior to such transaction or proxy contest constitute less than a majority of the Board thereafter; or

(c) during any period of two consecutive years, individuals who at the beginning of such period constituted the Board (including, without limitation, for this purpose any new director whose election or nomination for election by the Company’s shareholders was approved by a vote of at least a majority of the directors then still in office who were directors at the beginning of such period) cease for any reason to constitute at least a majority of the Board.

2. Liability Insurance.

(a) Maintenance of Insurance. The Company agrees that as long as the Indemnitee shall continue to serve as an Agent and thereafter so long as the Indemnitee shall be subject to any Proceeding or possible Proceeding by reason of the fact that the Indemnitee is or was an Agent, the Company shall obtain and maintain in full force and effect directors and officers liability insurance from established and reputable insurers for the benefit of the Company and its Agents with aggregate limits not less than the limits of, and having other terms not less favorable to the insured persons than, the directors and officers liability insurance maintained by the Company as of the Effective Date (the “D&O Insurance”). The D&O Insurance shall not contain any provision that limits or impacts adversely any right or privilege granted to the Indemnitee under this Agreement.

(b) “Tail” Insurance.

(i) Upon a Triggering Event; or

(ii) in the event that the D&O Insurance is to be cancelled or terminated or will not be renewed (such cancellation, termination or non-renewal being called a “Lapse Event”);

the Company shall purchase prepaid “tail” insurance for the Company and its Agents who are covered by the D&O Insurance for a term of six years following the Triggering Event or Lapse Event. Such “tail” insurance shall provide aggregate limits of not less than the limits under the D&O Insurance in effect immediately prior to the Triggering Event or Lapse Event, shall have other terms not less favorable to the insured persons than under the D&O Insurance in effect immediately prior to the Triggering Event or Lapse Event with respect to claims arising from facts or events that occurred at or prior to the Triggering Event or the Lapse Event. No such “tail” insurance shall contain any provision that limits or impacts adversely any right or privilege granted under this Agreement. The “tail” insurance with respect to any Triggering Event shall be purchased and fully paid, and shall be in effect, as of the occurrence of the Triggering Event. The “tail” insurance with respect to any Lapse Event shall be purchased and fully paid, and shall be in effect, as of the occurrence of the Lapse Event. Nothing in this Section 2(b) shall alter, limit or eliminate any obligation of the Company to provide and maintain D&O Insurance, under Section 2(a), for the services of the Indemnitee as an Agent following the Triggering Event or Lapse Event.

3. Mandatory Indemnification. Except as otherwise provided in this Agreement, the Company shall indemnify the Indemnitee to the fullest extent permitted by the Florida Business Corporation Act as such law may from time to time be amended, as follows:

(a) Non-Derivative Actions. If the Indemnitee is or was a party to or is or was threatened to be made a party to any Proceeding (other than an action by or in the right of the Company) by reason of the fact that the Indemnitee is or was an Agent, or by reason of anything done or not done by the Indemnitee in any such capacity, the Indemnitee shall be indemnified against any and all Liabilities and Expenses actually and reasonably incurred by the Indemnitee in connection with the investigation, defense, settlement or appeal of such Proceeding if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or Proceeding, the Indemnitee had no reasonable cause to believe that the Indemnitee’s conduct was unlawful; and

(b) Derivative Actions. If the Indemnitee is or was a party to or is threatened to be made a party to any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of the fact that the Indemnitee is or was an Agent, or by reason of anything done or not done by the Indemnitee in any such capacity, the Indemnitee

shall be indemnified against any and any and all Liabilities and Expenses actually and reasonably incurred by the Indemnitee in connection with the investigation, defense, settlement or appeal of such Proceeding if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company; except that no indemnification under this Section 3(b) shall be made in respect of any claim, issue or matter as to which the Indemnitee shall have been finally adjudged to be liable to the Company, after the time for an appeal has expired, by a court of competent jurisdiction because of the willful misconduct of a culpable nature in the performance of the Indemnitee’s duty to the Company unless and only to the extent that the court in which such Proceeding was brought shall determine, upon application, that despite such adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such amounts which the court shall deem proper.

Notwithstanding the foregoing, the Company shall not be obligated to indemnify the Indemnitee for Liabilities or Expenses which have been paid directly to the Indemnitee under the D&O Insurance or any “tail” insurance described in Section 2(b).

4. Partial Indemnification. If the Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of any Liabilities or Expenses incurred by the Indemnitee in the investigation, defense, settlement or appeal of a Proceeding but the Indemnitee is not entitled, however, to indemnification for the total amount thereof, the Company shall nevertheless indemnify the Indemnitee for such total amount minus the portion thereof to which the Indemnitee is not entitled.

5. Advancement of Expenses; and Payment of Certain Fees.

(a) Mandatory Advancement. Subject to Section 9 below, the Company shall advance all Expenses incurred by the Indemnitee in connection with the investigation, defense, settlement or appeal of any Proceeding to which the Indemnitee is a party or is threatened to be made a party by reason of the fact that the Indemnitee is or was an Agent or by reason of anything done or not done by the Indemnitee in any such capacity. The Indemnitee hereby undertakes to repay such amounts advanced only if, and to the extent that, it shall ultimately be determined that the Indemnitee is not entitled to be indemnified by the Company as authorized under this Agreement. The advances to be made under this Section 5(a), shall be paid by the Company to the Indemnitee within twenty (20) days following the giving of notice by the Indemnitee to the Company for such advance together with an undertaking as described in this Section 5(a).

(b) Hourly Payments. In the event of any Proceeding against the Indemnitee with respect to which any indemnification of the Indemnitee under this Agreement applies or reasonably could apply, the Company shall pay the Indemnitee at the rate of Three Hundred Dollars ($300.00) for each hour reasonably spent by the Indemnitee for participating (at the request of the Company, or pursuant to any subpoena, court or

administrative order, or process agreed to in writing by the Company), in (i) the investigation of such Proceeding, (ii) any discovery in such Proceeding, or (iii) the trial of such Proceeding or any post-trial matters (including, without limitation, any appeal, with respect to such Proceeding). For all periods of less than one complete hour spent by the Indemnitee in any matters described in the immediately preceding sentence, the Indemnitee shall be entitled to a proportionate part of the hourly rate set forth in the immediately preceding sentence. The Indemnitee shall maintain detailed time records of all time expended by the Indemnitee in any matters described in the first sentence of this Section 5(b) including, without limitation, a detailed description of the activities of the Indemnitee with respect to such matters, and the Indemnitee shall furnish such pertinent records for the review and approval of the Company prior to each proposed payment to the Indemnitee under this Section 5(b), which approval shall not be unreasonably withheld or delayed by the Company.

6. Notice and Other Indemnification Procedures.

(a) Within thirty (30) days after the Indemnitee receives notice of a Proceeding, as to which indemnification, or advancement of Expenses, may pertain, the Indemnitee shall, if the Indemnitee believes that indemnification with respect thereto may be sought from the Company under this Agreement, give notice to the Company of such Proceeding; provided, however, that failure of the Indemnitee to give such notice during such thirty (30) day period shall not alter, limit or eliminate the Indemnitee’s right to indemnification under this Agreement with respect to such Proceeding.

(b) The Company shall give prompt notice, that the Company has received, of such Proceeding to the insurers of the D&O Insurance or the “tail” insurance described in Section 2(b) in accordance with the procedures set forth in the applicable insurance policy or policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policy or policies.

(c) In the event the Company shall be obligated under this Agreement to advance Expenses to the Indemnitee with respect to any Proceeding, the Company shall be entitled to assume the defense of such Proceeding, with counsel approved by the Indemnitee, upon notice being given to the Indemnitee of its election so to do. After such notice has been given, approval of such counsel by the Indemnitee and the retention of such counsel by the Company, except as provided in Section 6(d), the Company will not be liable to the Indemnitee under this Agreement for any fees or expenses of counsel subsequently incurred by the Indemnitee with respect to such Proceeding. The Indemnitee shall have the right to employ the Indemnitee’s separate counsel in any such Proceeding at the Indemnitee’s expense.

(d) In the event that:

(i) the Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and the Indemnitee with respect to the defense of such Proceeding;

(ii) the Company shall not have engaged counsel to assume the defense of such Proceeding within a reasonable time after the Company has notice of such Proceeding; or

(iii) the Company, having assumed the defense of such Proceeding, does not vigorously defend such Proceeding;

the fees and expenses of the Indemnitee’s counsel shall be paid by the Company.

7.Determination of Right to Indemnification.

(a) To the extent the Indemnitee has been successful on the merits or otherwise in defense of any Proceeding referred to in Section 3(a) or Section 3(b) of this Agreement or in the defense of any claim, issue or matter described therein, the Company shall indemnify the Indemnitee against Liabilities and Expenses actually and reasonably incurred by the Indemnitee in connection therewith.

(b) In the event that Section 7(a) is inapplicable, the Company shall nevertheless indemnify the Indemnitee unless, and only to the extent that, the Company shall prove by clear and convincing evidence to a forum described in Section 7(c) below that the Indemnitee has not met the applicable standard of conduct required to entitle the Indemnitee to such indemnification.

(c) The Indemnitee shall be entitled to select, from among the following, the forum in which the validity of the Company’s claim under Section 7(b) that the Indemnitee is not entitled to indemnification will be heard:

(i)the Board, by majority vote of the Disinterested Directors whether or not such majority constitutes a quorum;

(ii)the majority vote of a committee of Disinterested Directors designated by the Board in the manner described in clause (i);

(iii)Independent Counsel, in a written opinion to the Board, or a committee described in clause (ii) above, with a copy to the Indemnitee, which Independent Counsel shall have been selected by the Board, in the manner described in clause (i) above, or by a committee, described in clause (ii) above, in the manner described in clause (ii);

(iv)the Company’s shareholders who are not parties or threatened parties to the Proceeding, by a majority vote of such shareholders in attendance at a meeting at which a quorum of such shareholders is present; or

(v)a panel of three arbitrators, one of whom is selected by the Company, another of whom is selected by the Indemnitee and the last of whom is selected by the first two arbitrators so selected.

(d) As soon as practicable, and in no event later than 30 days after notice of the Indemnitee’s choice of forum pursuant to Section 7(c) above has been given, the Company shall, at its own expense, submit to the selected forum in such manner as the Indemnitee or the Indemnitee’s counsel may reasonably request, the Company’s claim (if any) that the Indemnitee is not entitled to indemnification, and the Company shall act in the utmost good faith to assure the Indemnitee a complete opportunity to defend against such claim.

(e) Notwithstanding a determination by any forum listed in Section 7(c) hereof that the Indemnitee is not entitled to indemnification with respect to a specific Proceeding, the Indemnitee shall have the right to apply to the court in which that Proceeding is or was pending or any other court of competent jurisdiction, for the purpose of enforcing the Indemnitee’s right to indemnification pursuant to this Agreement.

(f) The Company agrees that if there is a Triggering Event (other than a Triggering Event that has been approved by a majority of members the Board which majority were directors immediately prior to such Triggering Event) then with respect to all matters thereafter arising concerning the rights of the Indemnitee to indemnification under the Company’s articles of incorporation or bylaws, this Agreement or any other agreement, or any other document now or hereafter in effect relating to such indemnification, the Company shall seek legal advice only from Independent Counsel selected by the Indemnitee. The Company agrees to pay the reasonable fees of such Independent Counsel and to indemnify fully such counsel against any and all attorneys’ fees and expenses, claims, liabilities and damages arising out of or relating to this Agreement or such Independent Counsel’s engagement pursuant hereto.

(g) The Company shall indemnify the Indemnitee against all Expenses incurred by the Indemnitee in connection with any Proceeding under this Section 7 involving the Indemnitee and against all Expenses incurred by the Indemnitee in connection with any other Proceeding between the Company and the Indemnitee involving the interpretation or enforcement of the rights of the Indemnitee under this Agreement unless a court of competent jurisdiction has determined, by a final, non-appealable judgment, that the material claims or defenses of the Indemnitee in any such Proceeding were frivolous or not made in good faith.

8. Notice of Claims Against Indemnitee. It shall be a condition precedent to the assertion by or on behalf of the Company or any Subsidiary of a claim against the Indemnitee, the Indemnitee’s spouse, heirs, estate or personal representatives that notice of such claim shall have been given to the Indemnitee within one year after the act or omission of the Indemnitee upon which such claim is based; provided, however, if the Indemnitee has fraudulently concealed the facts underlying such claim, it shall be a condition precedent to the assertion

by or on behalf of the Company or any Subsidiary of a claim against the Indemnitee, the Indemnitee’s spouse, heirs, estate or personal representatives that notice of such claim shall have been given to the Indemnitee within one year after the earlier of: (a) the date on which the Company or any Subsidiary discovered such facts; or (b) the date on which the Company or any Subsidiary could have discovered such facts by the exercise of reasonable diligence. This Section 8 shall not apply to any cause of action that has accrued prior to the Effective Date and as to which the Indemnitee is aware on the Effective Date, but as to which the Company has no actual knowledge apart from the Indemnitee’s knowledge.

9. Exceptions. Any other provision of this Agreement to the contrary notwithstanding, the Company shall not be obligated pursuant to the terms of this Agreement to:

(a) Indemnify the Indemnitee or advance Expenses to the Indemnitee with respect to Proceedings initiated or brought voluntarily by the Indemnitee and not by way of defense, except with respect to Proceedings brought to establish or enforce a right to indemnification under this Agreement or any other statute or law or otherwise as required under Florida law, but such indemnification or advancement of Expenses may be provided by the Company in specific cases if the Board determines it to be appropriate; or

(b) indemnify the Indemnitee for any Expenses incurred by the Indemnitee with respect to any Proceeding instituted by the Indemnitee to enforce or interpret this Agreement, if a court of competent jurisdiction determines, by a final, non-appealable judgment, that the material assertions made by the Indemnitee in such Proceeding were not made in good faith or were frivolous; or

(c) indemnify the Indemnitee under this Agreement for any amounts paid in settlement of a Proceeding unless the Company consents to such settlement; or

(d) indemnify the Indemnitee or advance Expenses to the Indemnitee under this Agreement with respect to any Proceeding brought by the Company against the Indemnitee for willful misconduct, unless a court of competent jurisdiction shall have determined by a final, non-appealable judgment, that the claims by the Company in such Proceeding were not made in good faith or were frivolous; or

(e) indemnify the Indemnitee for Expenses and the payment of profits arising from the purchase and sale by the Indemnitee of securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute; or

(f) indemnify the Indemnitee on account of the Indemnitee’s conduct which is finally adjudged by a final, non-appealable judgment of a court of competent jurisdiction to have been knowingly fraudulent or deliberately dishonest, or to constitute willful misconduct; or

(g) indemnify the Indemnitee if a final, non-appealable judgment of a court of competent jurisdiction shall have determined that such indemnification is not lawful; or

(h) indemnify the Indemnitee for the payment of amounts required to be reimbursed to the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002, as amended, or any similar successor statute.

10. Non-Exclusivity. The provisions for indemnification and advancement of Expenses under the terms of this Agreement shall not be deemed exclusive of any other rights which the Indemnitee may have under any provision of law, the Company’s articles of incorporation or bylaws, the vote of the Company’s shareholders or disinterested directors, other agreements, or otherwise, both as to actions in the Indemnitee’s official capacity and to actions in any other capacity while occupying the Indemnitee’s position as an Agent, and the Indemnitee’s rights under this Agreement shall continue after the Indemnitee has ceased acting as an Agent and shall inure to the benefit of the heirs, estate and personal representatives of the Indemnitee.

11. Interpretation of Agreement. The parties intend that this Agreement will be interpreted and enforced so as to provide indemnification to the Indemnitee to the fullest extent now or hereafter permitted by law.

12. Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever, (a) the validity, legality and enforceability of the remaining provisions of the Agreement (including, without limitation, all portions of any Sections of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby, and (b) to the fullest extent possible, the provisions of this Agreement (including, without limitation, all portions of any Sections of this Agreement containing any such provisions held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provisions held invalid, illegal or unenforceable and to give effect to Section 11 hereof.

13. Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision of this Agreement (whether or not similar) nor shall such waiver constitute a continuing waiver.

14. Successors and Assigns. The terms of this Agreement shall bind, and shall inure to the benefit of, the Company and its successors and permitted assigns, on the one hand, and the Indemnitee and the Indemnitee’s heirs, estate, personal representatives and permitted assigns, on the other hand. Neither party may assign any of its rights or delegate any of its duties under this Agreement without the prior written consent of the other party, which consent may be granted or withheld in the sole discretion of the other party.

15. Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed duly given and received (a) when delivered by hand and receipted for by the party addressee, (b) when delivered by nationally recognized courier service, or (c) on the fifth day after being mailed by certified or registered mail with postage prepaid, return receipt requested, and in each of the foregoing cases, addressed to intended party at the address of such party shown on the signature page of this Agreement. Either party may change such party’s address for the giving of notices, requests, demands and other communications, or the person to whose attention such notices, requests, demands and other communications are to be given, by giving notice of such change to the other party in accordance with this Section.

16. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida without taking into account conflicts of laws rules or principles that could result in the application of the laws of any other jurisdiction.

17. Consent to Jurisdiction. The Company and the Indemnitee each hereby irrevocably consent to the exclusive jurisdiction and venue of the courts of the State of Florida for all purposes in connection with any Proceeding which arises out of or relates to this Agreement.

[Signature Page Follows]

The parties hereto have entered into this Indemnification Agreement effective as of the Effective Date.

	THE COMPANY:
	PERFUMANIA HOLDINGS, INC.
By:
Name:
Title:
Address of the Company:
Name:
Address of the Indemnitee:

EX-31.1

Exhibit 31.1

CERTIFICATIONS

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Michael W. Katz, certify that:

(1) I have reviewed this report on Form 10-Q of Perfumania Holdings, Inc.;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 19, 2017

By: /s/ Michael W. Katz

Michael W. Katz

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Michael P. Nofi, certify that:

(1) I have reviewed this report on Form 10-Q of Perfumania Holdings, Inc.;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 19, 2017

By: /s/ Michael P. Nofi

Michael P. Nofi

Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Perfumania Holdings, Inc. (the “Company”) on Form 10-Q for the period ended April 29, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Michael W. Katz, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By: /s/ Michael W. Katz

Michael W. Katz

President and Chief Executive Officer

June 19, 2017

EX-32.2

Exhibit 32.2

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Perfumania Holdings, Inc. (the “Company”) on Form 10-Q for the period ended April 29, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Michael P. Nofi, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By: /s/ Michael P. Nofi

Michael P. Nofi

Chief Financial Officer

June 19, 2017

XML

Document and Entity Information - shares	3 Months Ended
	Apr. 29, 2017	Jun. 16, 2017
Entity Information [Line Items]
Entity Registrant Name	Perfumania Holdings, Inc.
Entity Central Index Key	0000880460
Current Fiscal Year End Date	--02-03
Entity Filer Category	Smaller Reporting Company
Document Type	10-Q
Document Period End Date	Apr. 29, 2017
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		15,493,763

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 28, 2017
Current assets:
Cash	$ 1,848	$ 7,474
Accounts receivable, net of allowances of $3,016 and $1,233 as of April 30, 2016 and January 30, 2016 respectively	31,614	28,072
Inventory, Net	193,083	196,654
Prepaid expenses and other current assets	9,829	10,619
Total current assets	236,374	242,819
Property and equipment, net	15,818	16,692
Goodwill	38,769	38,769
Intangible and other assets, net	13,778	14,520
Total assets	304,739	312,800
Current liabilities:
Accounts payable	27,506	28,605
Accounts payable-affiliates	546	1,027
Accrued expenses and other liabilities	28,507	31,186
Current portion of obligations under capital leases	898	1,237
Total current liabilities	57,457	62,055
Revolving credit facility	4,517	0
Notes payable, affiliates	125,366	125,366
Other long-term liabilities	66,593	64,954
Total liabilities	253,933	252,375
Commitments and contingencies
Shareholders’ equity:
Preferred stock, $0.10 par value, 1,000,000 shares authorized, as of April 30, 2016 and January 30, 2016, none issued	0	0
Common stock, $0.01 par value, 35,000,000 shares authorized;16,392,012 shares issued as of April 30, 2016 and January 30, 2016	164	164
Additional paid-in capital	222,082	222,048
Accumulated deficit	(162,863)	(153,210)
Treasury stock, at cost, 898,249 shares as of April 30, 2016 and January 30, 2016	(8,577)	(8,577)
Total shareholders’ equity	50,806	60,425
Total liabilities and shareholders’ equity	$ 304,739	$ 312,800

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 29, 2016	Jan. 30, 2016
Accounts receivable, allowance for doubtful accounts	$ 3,016	$ 1,233
Preferred stock par value	$ 0.10	$ 0.10
Preferred stock shares authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0
Common stock par value	$ 0.01	$ 0.01
Common stock shares authorized	35,000,000	35,000,000
Common stock shares issued	16,392,012	16,392,012
Treasury stock shares	898,249	898,249

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Net sales	$ 97,896	$ 105,139
Cost of goods sold	52,927	53,370
Gross profit	44,969	51,769
Operating expenses:
Selling, General and Administrative Expenses	50,932	53,928
Share-based compensation expense	34	32
Depreciation and amortization	1,531	2,511
Total operating expenses	52,497	56,471
Income (loss) from operations	(7,528)	(4,702)
Interest expense	2,125	1,707
Income (loss) before income tax provision	(9,653)	(6,409)
Income Tax Provision	0	0
Net income (loss)	$ (9,653)	$ (6,409)
Net income (loss) per common share:
Basic and diluted	$ (0.62)	$ (0.41)
Weighted average number of common shares outstanding:
Basic	15,493,763	15,493,763
Diluted	15,493,763	15,493,763

XML

Condensed Consolidated Statement of Shareholders' Equity - 3 months ended Apr. 29, 2017 - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]
Balance, shares at Jan. 28, 2017		16,392,012			898,249
Balance at Jan. 28, 2017	$ 60,425	$ 164	$ 222,048	$ (153,210)	$ (8,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	34		34
Net loss	(9,653)			(9,653)
Balance, shares at Apr. 29, 2017		16,392,012			898,249
Balance at Apr. 29, 2017	$ 50,806	$ 164	$ 222,082	$ (162,863)	$ (8,577)

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Cash flows from operating activities:
Net loss	$ (9,653)	$ (6,409)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred financing costs	86	86
Depreciation and amortization	1,531	2,511
Provision (recovery) for losses on accounts receivable	164	1,787
Share-based compensation expense	34	32
Change in operating assets and liabilities net of effect of acquisition:
Accounts receivable	(3,706)	(7,181)
Inventories	3,571	7,487
Prepaid expenses and other assets	1,084	405
Accounts payable	(1,099)	1,919
Accounts payable-affiliates	(481)	(120)
Accrued expenses and other liabilities and other long-term liabilities	(1,040)	(1,187)
Net cash used in operating activities	(9,509)	(670)
Cash flows from investing activities:
Additions to property and equipment	(295)	(809)
Net cash used in investing activities	(295)	(809)
Cash flows from financing activities:
Net (repayments) borrowings under bank line of credit	4,517	(989)
Principal payments under capital lease obligations	(339)	(285)
Net cash provided by financing activities	4,178	(1,274)
Net decrease in cash and cash equivalents	(5,626)	(2,753)
Cash and cash equivalents at beginning of period	7,474	5,640
Cash and cash equivalents at end of period	1,848	2,887
Supplemental Information:
Cash paid during the period for Interest	71	214
Cash paid during the period for Income taxes	$ 17	$ 109

XML

Basis of Presentation and Operations

3 Months Ended

Apr. 29, 2017

Basis of Presentation and Operations [Abstract]

Basis of Presentation and Operations

BASIS OF PRESENTATION AND OPERATIONS

The condensed consolidated balance sheet of Perfumania Holdings, Inc. and Subsidiaries (the "Company") as of January 28, 2017, which has been derived from our audited financial statements as of and for the year ended January 28, 2017, and the accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. Certain information and note disclosures normally included in annual financial statements, prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), have been condensed or omitted pursuant to those rules and regulations. The financial information presented herein, which is not necessarily indicative of results to be expected for the full current fiscal year, reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the interim unaudited condensed consolidated financial statements. Such adjustments are of a normal, recurring nature. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended January 28, 2017.

Due to the seasonality of the Company’s business, with the most significant activity occurring from September through December each year, the results of operations for the thirteen weeks ended April 29, 2017 are not necessarily indicative of results to be expected for the full fiscal year.

The Company is an independent, national, vertically integrated wholesale distributor and specialty retailer of perfumes and fragrances that conducts business through six wholly-owned operating subsidiaries; Perfumania, Inc. (“Perfumania”), Quality King Fragrance, Inc. (“QFG”), Perfumania.com, Inc. (“Perfumania.com”), Parlux Fragrances, LLC ("Parlux"), Five Star Fragrance Company, Inc. (“Five Star”) and Scents of Worth, Inc. ("SOW"). We operate in two industry segments, wholesale distribution and specialty retail sales of designer fragrances and related products.

Our wholesale businesses include QFG, Parlux and Five Star. QFG distributes designer fragrances to mass market retailers, drug and other chain stores, retail wholesale clubs, traditional wholesalers, and other distributors throughout the United States. The Company sells principally to retailers such as Burlington Coat Factory, CVS, Kohl's, Marshalls, Nordstrom Rack, Ross Stores, Sears, Target, Wal-Mart and Walgreens. The Company’s manufacturing divisions, Parlux and Five Star, own and license designer and other fragrance brands that are sold to regional and national department stores, including Belk, Bon Ton, Boscovs, Dillards, Lord & Taylor, Macy's and Stage Stores, international distributors, on military bases throughout the United States, by QFG and through the Company's retail business which is discussed below. Parlux also fulfills a selection of fragrances for several online retailers, shipping directly to their customers and billing the retailers. Five Star also manufactures, on behalf of Perfumania, the Jerome Privee product line, which includes bath and body products and which is sold exclusively in Perfumania's retail stores. All manufacturing operations of Parlux and Five Star are outsourced.

Our retail business is conducted through the following subsidiaries:

•Perfumania, a specialty retailer of fragrances and related products,

•Perfumania.com, an Internet retailer of fragrances and other specialty items, and

•SOW, which sells fragrances in retail stores on a consignment basis.

As of April 29, 2017, Perfumania operated a chain of 240 retail stores specializing in the sale of fragrances and related products at discounted prices up to 75% below the manufacturers’ suggested retail prices. Perfumania.com, our Company-owned website, offers a selection of our more popular products for sale online. SOW operates a national designer fragrance consignment program, with contractual relationships to sell products on a consignment basis in approximately 1,100 stores, including approximately 600 Kmart locations nationwide. Its other retail customers include Bealls, K & G and Steinmart.

XML

Recent Accounting Pronouncements

3 Months Ended

Apr. 29, 2017

RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]

Recent Accounting Pronouncements

RECENT ACCOUNTING PRONOUNCEMENTS

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330). The amendments, which apply to inventory that is measured using any method other than the last-in, first-out (LIFO) or retail inventory method, require that entities measure inventory at the lower of cost or net realizable value. ASU 2015-11 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016 and should be applied on a prospective basis. The Company adopted ASU No. 2015-11 prospectively effective January 29, 2017. There was no impact to the Company's consolidated financial statements.

XML

Allowance for Doubtful Accounts (Notes)

3 Months Ended

Apr. 29, 2017

Receivables [Abstract]

Allowance for Credit Losses [Text Block]

ALLOWANCE FOR DOUBTFUL ACCOUNTS

The Company's accounts receivable consist primarily of trade receivables due from wholesale customers. In May 2016, a Panama based customer of Parlux that distributes in certain Latin American countries was placed on the Specially Designated Nationals list by the Office of Foreign Assets Control of the U.S. Treasury Department. As a result, the customer's assets have been frozen and any dealings between U.S. companies, including Parlux, and the customer have been prohibited. Accordingly, during the thirteen weeks ended April 30, 2016, management reserved the outstanding accounts receivable balance from the customer of approximately $1.7 million due to the uncertainty of future collection of these receivables.

XML

Goodwill and Intangible Assets

3 Months Ended

Apr. 29, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

GOODWILL AND INTANGIBLE ASSETS

Goodwill in the amount of $38.8 million at April 29, 2017 and January 28, 2017 resulted from the April 18, 2012 acquisition of Parlux.

The following table provides information related to goodwill and intangible assets (in thousands). Intangible assets are included in intangible and other assets, net on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017:

		April 29, 2017						January 28, 2017
	Useful Life (years)	Original Cost		Accumulated Amortization		Net Book Value		Original Cost		Accumulated Amortization		Net Book Value
Goodwill	N/A	$	38,769	$	—	$	38,769	$	38,769	$	—	$	38,769
Tradenames	4-20	9,357		8,181		1,176		9,357		8,084		1,273
Customer relationships	10	5,171		2,629		2,542		5,171		2,500		2,671
Favorable leases	7	886		886		—		886		886		—
License agreements	3-5	16,313		15,779		534		16,313		15,643		670
Tradename (non-amortizing)	N/A	7,180		—		7,180		7,180		—		7,180
		$	77,676	$	27,475	$	50,201	$	77,676	$	27,113	$	50,563

In accordance with US GAAP, goodwill and intangible assets with indefinite lives are not amortized, but rather tested for impairment at least annually by comparing the estimated fair values to their carrying values.

Trademarks, including tradenames and owned licenses having finite lives, are amortized over their respective lives to their estimated residual values and are also reviewed for impairment in accordance with accounting standards when changes in circumstances indicate the assets’ values may be impaired. Customer relationships are amortized over the expected period of benefit and license agreements are amortized over the remaining contractual term. Impairment testing is based on a review of forecasted operating cash flows and the profitability of the related brand to determine its fair value. There were no triggering events during the thirteen weeks ended April 29, 2017 that would indicate potential impairment and the requirement to review the carrying value of goodwill and intangible assets.

Amortization expense associated with intangible assets subject to amortization is included in depreciation and amortization on the accompanying condensed consolidated statements of operations. Amortization expense for intangible assets subject to amortization was $0.4 million and $0.9 million during the thirteen-weeks ended April 29, 2017 and April 30, 2016, respectively. As of April 29, 2017, estimated future amortization expense associated with intangible assets subject to amortization is as follows (in thousands):

Fiscal Year	Amortization Expense
Remainder of 2017	$	1,065
2018	877
2019	709
2020	684
2021	682
2022	235
	$	4,252

XML

Accounting For Share-Based Payments

3 Months Ended

Apr. 29, 2017

ACCOUNTING FOR SHARE-BASED PAYMENTS [Abstract]

Accounting for Share-Based Payments

ACCOUNTING FOR SHARE-BASED PAYMENTS

The 2010 Equity Incentive Plan (the “2010 Plan”) provides for equity-based awards to the Company’s employees, directors and consultants. Under the 2010 Plan, the Company initially reserved 1,000,000 shares of common stock for issuance. This number automatically increases on the first trading day of each fiscal year beginning with fiscal 2011, by an amount equal to 1.5% of the shares of common stock outstanding as of the last trading day of the immediately preceding fiscal year; accordingly, 2,426,711 shares of common stock were reserved for issuance as of April 29, 2017. The Company previously had two stock option plans which expired on October 31, 2010. No further awards will be granted under these plans, although all options previously granted and outstanding will remain outstanding until they are either exercised or forfeited. As of April 29, 2017, 1,059,252 stock options have been granted pursuant to the 2010 Plan.

The following is a summary of the stock option activity during the thirteen weeks ended April 29, 2017:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 28, 2017	1,184,000		$	6.07
Granted	—		—
Exercised	—		—
Forfeited	(100,000	)	7.70
Outstanding as of April 29, 2017	1,084,000		$	5.92	6.9	$	—
Vested and expected to vest as of April 29, 2017	709,834		$	7.79	6.9	$	—
Exercisable as of April 29, 2017	709,834		$	7.79	6.9	$	—

The following is a summary of stock warrants activity during the thirteen weeks ended April 29, 2017:

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 28, 2017	6,299,971		$	11.80
Granted	—		—
Exercised	—		—
Forfeited	(2,133,332	)	8.00
Outstanding as of April 29, 2017	4,166,639		$	13.74	1.8	$	—
Vested and expected to vest as of April 29, 2017	4,166,639		$	13.74	1.8	$	—
Exercisable as of April 29, 2017	4,166,639		$	13.74	1.8	$	—

Share-based compensation expense was less than $0.1 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016.

XML

Revolving Credit Facility and Notes Payable to Affiliates

3 Months Ended

Apr. 29, 2017

REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES [Abstract]

Revolving Credit Facility and Notes Payable to Affiliates

REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES

The Company’s revolving credit facility and notes payable to affiliates consist of the following:

	April 29, 2017		January 28, 2017
	(in thousands)
Revolving credit facility, interest payable monthly, secured by a pledge of substantially all of the Company's assets	$	4,517	$	—
Subordinated notes payable-affiliates	125,366		125,366
	129,883		125,366
Less current portion	—		—
Total long-term debt	$	129,883	$	125,366

The Company has a revolving Senior Credit Facility with a syndicate of banks that is used for the Company’s general corporate purposes including working capital and capital expenditures. The maximum borrowing amount under the Senior Credit Facility is $175 million and the termination date is April 2019. Under this facility, which does not require amortization of principal, revolving loans may be drawn, repaid and reborrowed up to the amount available under a borrowing base calculated with reference to specified percentages of the Company’s credit card and trade receivables and inventory, which may be reduced by the lender in its reasonable discretion. The Company mustmaintain excess availability under the facility of at least$10 million. As ofApril 29, 2017, the Company had$80.1 millionof net availability which includes $25 million for letters of credit.

Interest under the Senior Credit Facility is at variable rates plus specified margins that are determined based upon the Company’s excess availability from time to time. The Company is also required to pay monthly commitment fees based on the unused amount of the Senior Credit Facility and a monthly fee with respect to outstanding letters of credit. As of April 29, 2017, the interest rate on outstanding borrowings was 5.0%.

All obligations of the Company related to the Senior Credit Facility are secured by first priority perfected security interests in all personal and real property owned by the Company, including without limitation 100% (or, in the case of excluded foreign subsidiaries, 66%) of the outstanding equity interests in the subsidiaries. The Company is subject to customary limitations on its ability to, among other things, pay dividends and make distributions, make investments and enter into joint ventures, and dispose of assets. The Company was in compliance with all financial and operating covenants as of April 29, 2017.

In addition, the Company has outstanding unsecured debt obligations to affiliates as follows:

(i)a promissory note in the principal amount of $35 million, (the “QKD Note”) held by Quality King Distributors, Inc. ("Quality King"), which provides for payment of principal in quarterly installments between July 31, 2019 and October 31, 2022, with a final installment on October 31, 2022 of the remaining balance, and payment of interest in quarterly installments commencing on January 31, 2011 at the then current senior debt rate, as defined in the Senior Credit Facility, plus 1% per annum;

(ii)promissory notes in the aggregate principal amount of approximately $85.4 million held by six estate trusts established by Glenn, Stephen and Arlene Nussdorf (the “Nussdorf Trust Notes”), which provide for payment of the principal in full on July 31, 2019 and payments of interest in quarterly installments commencing on July 31, 2012 at the then current senior debt rate plus 2% per annum; and

(iii)    a promissory note in the principal amount of $5 million held by Glenn and Stephen Nussdorf (the “2004 Note”), which provided for payment in January 2009 and is currently in default because of the restrictions on payment described below, resulting in an increase of 2% in the nominal interest rate, which is the prime rate plus 1%.

These notes are subordinated to the Senior Credit Facility. No principal may be paid on any of them until three months after the Senior Credit Facility terminates and is paid in full, and payment of interest is subject to satisfaction of certain conditions, including the Company’s maintaining excess availability under the Senior Credit Facility of the greater of $17.5 million or 17.5% of the borrowing base certificate after giving effect to the payment, and a fixed charge coverage ratio, as defined in the credit agreement, of 1.1:1.0. Interest expense on these notes was approximately $2.1 million and $1.5 million for the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively, and is included in interest expense on the accompanying condensed consolidated statements of operations. No payments of principal or interest have been made on the QKD Note or the Nussdorf Trust Notes. On the 2004 Note, no payments of principal have been made and no interest payments have been made since October 2008. Accrued interest payable due at April 29, 2017 and January 28, 2017 on the Nussdorf Trust Notes, the QKD Note, and the 2004 Note was approximately $52.9 million and $50.8 million, respectively, and is included in other long-term liabilities on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017, respectively.

XML

Accounting for Income Taxes

3 Months Ended

Apr. 29, 2017

ACCOUNTING FOR INCOME TAXES [Abstract]

Accounting for Income Taxes

ACCOUNTING FOR INCOME TAXES

The Company conducts business throughout the United States, Puerto Rico and the United States Virgin Islands and, as a result, files income tax returns in the U.S. Federal and various state jurisdictions, Puerto Rico and the United States Virgin Islands. In the normal course of business, the Company is subject to examinations in these jurisdictions. With few exceptions, the Company is no longer subject to U.S. Federal, state, local or Puerto Rico income tax examinations for fiscal years prior to 2008. State and foreign income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any Federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

The Company continues to provide a full valuation allowance against its net deferred tax assets due to the uncertainty as to when and if business conditions will improve sufficiently to enable it to utilize its deferred tax assets. The Company did not record a Federal or state tax expense for the thirteen-week periods ended April 29, 2017 and April 30, 2016, since the Company had a cumulative operating loss for each thirteen-week period.

During the thirteen weeks ended April 29, 2017, there were no changes to the liability for income tax associated with uncertain tax positions. The Company accrues interest related to unrecognized tax benefits as well as any related penalties in the income tax provision in its condensed consolidated statements of operations, which is consistent with the recognition of these items in prior reporting periods. The accrual for interest and penalties related to uncertain tax positions as of April 29, 2017 and January 28, 2017 was not significant.

The Company does not anticipate any material adjustments relating to unrecognized tax benefits within the next twelve months; however, the ultimate outcome of tax matters is uncertain and unforeseen results can occur.

XML

Basic and Diluted Net Loss Per Common Share

3 Months Ended

Apr. 29, 2017

Earnings Per Share [Abstract]

Basic and Diluted Net Loss Per Common Share

BASIC AND DILUTED NET LOSS PER COMMON SHARE

Basic net loss per common share has been computed by dividing net loss by the weighted average number of common shares outstanding during the period.

Diluted net loss per common share includes, in periods in which they are dilutive, the effect of those potentially dilutive securities where the average market price of the common stock exceeds the exercise prices for the respective periods.

During the thirteen-week periods ended April 29, 2017 and April 30, 2016 there were 5,250,639 and 7,135,556, respectively, potential shares of common stock which were excluded from the diluted loss per share calculation because the effect of including these potential shares would have been antidilutive.

XML

Fair Value Measurements

3 Months Ended

Apr. 29, 2017

FAIR VALUE MEASUREMENTS [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

The Company applies authoritative accounting guidance regarding fair value and disclosures as it applies to financial and non-financial assets and liabilities. The guidance defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows:

Level 1: Observable inputs such as quoted prices in active markets (the fair value hierarchy gives the highest priority to

Level 1 inputs);

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs in which there is little or no market data and require the reporting entity to develop its own assumptions.

As of April 29, 2017, the Company had no material financial assets or liabilities measured on a recurring basis at fair value. The Company measures certain assets at fair value on a non-recurring basis, specifically long-lived assets evaluated for impairment. No such impairments were recorded during the thirteen-week periods ended April 29, 2017 and April 30, 2016.

The fair values of the Company’s assets and liabilities that qualify as financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and short-term debt are carried at cost, which approximates fair value due to the short-term maturity of these instruments. The reported amounts of long-term obligations approximate fair value, given management’s evaluation of the instruments’ current rates compared to market rates of interest and other factors.

XML

Contingencies

3 Months Ended

Apr. 29, 2017

CONTINGENCIES [Abstract]

Contingencies

CONTINGENCIES

On February 21, 2017, Kiss Nail Products, Inc. (Plaintiff) sued Parlux and Roraj Trade, LLC (the licensor of Rihanna’s intellectual property), ("Defendants"), in the U.S. District Court for the Southern District of New York alleging both federal and state law trademark infringement and unfair competition arising out of Parlux’s sale and distribution of the “Kiss by Rihanna” fragrance. Plaintiff alleges that such sale and distribution infringes its “Kiss” mark on nail care and other beauty products. Plaintiff seeks, inter alia, to enjoin Defendants’ distribution and sales of the alleged offending products and seeks unspecified money damages as well as treble damages, attorneys’ fees, punitive damages and interest. Pursuant to an agreement between Parlux and Roraj, Parlux has agreed to defend and indemnify Roraj in this case. On April 19, 2017, the Defendants filed an Answer in the nature of a general denial along with Counterclaims seeking a declaratory judgment that Plaintiff has abandoned the mark with regard to perfume, fragrance, cologne and related fragrance products. Defendants are also seeking a declaration that they have not infringed any of Plaintiff’s marks. The Court has set a schedule which calls for the conclusion of fact and expert discovery on or about December 20, 2017, with dispositive motion practice likely to follow. The Court has also referred the case to a Magistrate Judge for a settlement conference.

In August 2015, the Company was named as a defendant in a class action filed in the Superior Court for the State of California, County of Ventura. The plaintiff, a former employee of Perfumania, sought to represent all current and former sales associates at California Perfumania stores. The complaint alleged various violations of California law related to wages, meal periods and wage statements, among other things. In October 2016, the parties agreed in principle on a settlement which has been submitted to the Court. The settlement proceeds will be deposited with the settlement administrator when the court provides its final approval, which is expected sometime in 2017. The Company accrued the estimated settlement of approximately $0.5 million during the thirteen weeks ended October 29, 2016.

In November 2015, the Company was named as a defendant in a putative class action in the U.S. District Court for the Southern District of Alabama. The complaint, and thereafter an amended complaint, alleged that the Company violated the Telephone Consumer Protection Act ("TCPA") by sending unsolicited facsimiles which advertised goods and/or services offered by the Company. The plaintiff sought to represent a nationwide class of all recipients of such unsolicited faxes for the period November 3, 2011 to the present. Plaintiff sought statutory damages of at least $500 per violative fax, plus other non-monetary relief. The parties agreed to mediate the matter, which resulted in a settlement in principle. A formal settlement agreement, on a class wide basis, was entered into in late November 2016. Defendants will obtain a release, on a class wide basis, from all members of the settlement class who do not opt out, back to January 2011. The settlement has been preliminarily approved by the Court and notice has been disseminated to potential class members, who had the opportunity to opt out of the class or to object to the settlement on or before March 31, 2017. No objections have been received, but there have been four opt-outs and various claims. The settlement will be presented to the Court for final approval at a hearing currently scheduled for June 29, 2017. Assuming final approval, claims will be submitted, reviewed, and paid as appropriate. It is expected that this process will be concluded during calendar 2017. The Company accrued the estimated settlement of approximately $0.5 million during the thirteen weeks ended October 29, 2016.

The Company is involved in various legal proceedings in the ordinary course of business. Management cannot presently predict the outcome of these matters, although management believes, based in part on the advice of counsel, that the ultimate resolution of these matters will not have a materially adverse effect on the Company's consolidated financial position, results of operations or cash flows. See also the discussion of litigation with licensor in Note 11 of this Form 10-Q.

XML

Related Party Transactions

3 Months Ended

Apr. 29, 2017

Related Party Transactions [Abstract]

Related Party Transactions

RELATED-PARTY TRANSACTIONS

Glenn, Stephen and Arlene Nussdorf owned an aggregate 7,742,282 shares or approximately 50.0% of the total number of shares of the Company’s outstanding common stock as of April 29, 2017, excluding shares issuable upon exercise of certain warrants and not assuming the exercise of any outstanding options. Stephen Nussdorf has served as the Chairman of the Company’s Board of Directors since February 2004 and Executive Chairman of the Board since April 2011. Glenn Nussdorf is a director of subsidiaries of the Company.

The Nussdorfs are officers and principals of Quality King, which distributes pharmaceuticals and health and beauty care products, and the Company’s President and Chief Executive Officer, Michael W. Katz, is also an executive of Quality King.

See Note 6 for a discussion of notes payable to affiliates.

Transactions With Affiliated Companies

Glenn Nussdorf has an ownership interest in Lighthouse Beauty Marketing, LLC, Lighthouse Beauty, LLC and Lighthouse Beauty KLO, LLC (collectively the "Lighthouse Companies"), all of which are manufacturers and distributors of prestige fragrances and have been suppliers to the Company.

The Company purchases merchandise from Jacavi Beauty Supply, LLC (“Jacavi”), a fragrance distributor. Jacavi's managing member is Rene Garcia. Rene Garcia, his family trusts and related entities are members of a group (the "Garcia Group") that owned an aggregate 2,211,269 shares, or approximately 14.3%, of the total number of shares of the Company's outstanding common stock as of April 29, 2017, excluding shares issuable upon exercise of certain warrants. See disclosures of merchandise purchases in the table below.

The Company sells merchandise to Reba Americas LLC ("Reba"), which distributes fragrances primarily in Puerto Rico and the Caribbean. Family trusts of Rene Garcia own 50% of Reba. Net sales to Reba were approximately $1.1 million and $0.7 million during the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively. The balance due from Reba as of April 29, 2017 and January 28, 2017 was approximately $0.6 million and $0.4 million, respectively, and is included in accounts receivable, net of allowances, on the accompanying condensed consolidated balance sheets. The Company also purchased certain merchandise from Reba during the thirteen-week periods ended April 29, 2017 and April 30, 2016.

The amounts due to these related companies are non-interest bearing and are included in accounts payable-affiliates in the accompanying condensed consolidated balance sheets. Transactions for merchandise purchases with these related companies during the thirteen-week periods ended April 29, 2017 and April 30, 2016 were as follows (in thousands):

	Total Purchases Thirteen Weeks Ended April 29, 2017		Total Purchases Thirteen Weeks Ended April 30, 2016		Balance Due April 29, 2017		Balance Due January 28, 2017
Lighthouse Companies	$	—	$	—	$	90	$	90
Jacavi	311		1,449		—		590
Quality King	—		13		—		—
Reba	—		122		357		337
	$	311	$	1,584	$	447	$	1,017

Glenn, Stephen and Arlene Nussdorf own GSN Trucking, Inc. (“GSN”) which provides general transportation and freight services. The Company periodically utilizes GSN to transport both inbound purchases of merchandise and outbound shipments to wholesale customers. There were no payments to GSN during the thirteen weeks ended April 29, 2017. During the thirteen weeks ended April 30, 2016, total payments to GSN for transportation services provided were less than $0.1 million. There was no balance due to GSN at April 29, 2017 or January 28, 2017.

Quality King leases a 560,000 square foot facility in Bellport, NY. The Company began occupying approximately half of this facility in December 2007 under a sublease that terminates on September 30, 2027 and this location serves as the Company’s principal offices. As of April 29, 2017, the monthly current sublease payments are approximately $240,000 and increase by 3% annually. Total payments by the Company to Quality King for this sublease were approximately $0.7 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively.

The Company and Quality King are parties to a Services Agreement providing for the Company’s participation in certain third party arrangements at the Company’s respective share of Quality King’s cost, including allocated overhead, plus a 2% administrative fee, and the provision of legal services. The Company also shares with Quality King the economic benefit of the bulk rate contract that the Company has with UPS to ship Quality King’s merchandise and related items. The Services Agreement will terminate on thirty days’ written notice from either party. The expenses charged under these arrangements to the Company were $0.2 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016. The balance due to Quality King for expenses charged under the Services Agreement was $0.1 million and less than $0.1 million at April 29, 2017 and January 28, 2017, respectively.

On April 18, 2012, Parlux, Artistic Brands Development LLC (“Artistic Brands”) (a company controlled by Rene Garcia), Shawn C. Carter (who is the beneficial owner of 10% of the Company’s common stock) and S. Carter Enterprises, LLC entered into a sublicense agreement and Artistic Brands, Shawn Carter and S. Carter Enterprises, LLC entered into a license agreement. In connection with these agreements, the Company issued to Artistic Brands and its designees, including Shawn Carter, warrants for the purchase of an aggregate of 1,599,999 shares of the Company's common stock at an exercise price of $8.00 per share. Pursuant to the license agreement, Artistic Brands obtained the exclusive right and license to manufacture, promote, distribute, and sell prestige fragrances and related products under the Jay-Z trademark. The initial term of the license agreement expires at the earlier of (i) five years following the first date on which licensed products are shipped and (ii) December 31, 2018. Artistic Brands has the right to renew the license agreement, so long as certain financial conditions are met and it has not otherwise breached the agreement. Pursuant to the license agreement, Artistic Brands agreed to make certain royalty payments, including certain guaranteed minimum royalties. Pursuant to the sublicense agreement, Artistic Brands sublicensed all rights granted under the license agreement to the Company, and in return the Company assumed all of Artistic Brands' obligations under the license agreement, including making all royalty payments and certain guaranteed minimum royalties owed to S. Carter Enterprises, LLC. No royalties have been paid during the thirteen weeks ended April 29, 2017 or April 30, 2016.

On January 25, 2016, the Company and Parlux filed a lawsuit against S. Carter Enterprises, LLC and Shawn C. Carter in the Supreme Court of the State of New York, County of New York. In general, the lawsuit alleges that the defendants have breached the license described above and related agreements by not acting timely or in good faith in approving products and launches under the license and not supporting the brand via personal appearances as required by the license. The lawsuit seeks a determination that such breaches undermine the essence of the license thereby warranting rescission of the license, return of the consideration paid on account of the license and related agreements, monetary damages, and other relief. On May 6, 2016, the defendants filed an answer in the nature of a general denial, with a counterclaim for, inter alia, amounts allegedly due to them under the license agreements in the amount of approximately $2.7 million. The Company has filed a reply to that counterclaim in the nature of a general denial. The Court has set a schedule which calls for the conclusion of fact and expert discovery by January 2018, with dispositive motion practice to follow. On May 5, 2017, the defendants filed a motion for partial summary judgment on their counterclaim. The Company submitted opposition papers on June 9, 2017, and defendants have until June 30 to submit reply papers. Thereafter, the motion will be presented to the Court on July 5, 2017.

The Company has announced that a special committee of our independent directors is considering various alternatives to address the Company’s financial condition. The special committee is considering the Company’s capital structure and possible alternatives that could result in value to all shareholders, and has contacted members of the Nussdorf family, our principal shareholders, to begin discussions over possible approaches. The Company does not have a defined timeline for the strategic review process, and there can be no assurance that it will result in any strategic alternative being announced or consummated.

XML

Segment Information

3 Months Ended

Apr. 29, 2017

SEGMENT INFORMATION [Abstract]

Segment Information

SEGMENT INFORMATION

The Company operates in two industry segments, wholesale distribution and specialty retail sales of designer fragrance and related products. Management reviews segment information by segment and on a consolidated basis each month. Retail sales include sales through Perfumania retail stores, the SOW consignment business and the Company’s internet site, Perfumania.com. Wholesale sales include sales through QFG, Parlux and Five Star to unrelated customers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in the Annual Report on Form 10-K for the fiscal year ended January 28, 2017. The Company’s chief operating decision maker, who is its Chief Executive Officer, assesses segment performance by reference to gross profit. Each of the segments has its own assets, liabilities, revenues and cost of goods sold. While each segment has certain unallocated operating expenses, these expenses are not reviewed by the chief operating decision maker on a segment basis, but rather on a consolidated basis. Financial information for these segments is summarized in the following table:

	Thirteen Weeks Ended April 29, 2017			Thirteen Weeks Ended April 30, 2016
	(in thousands)
Net sales:
Wholesale	$	51,102		$	53,464
Retail	46,794			51,675
	$	97,896		$	105,139
Gross profit:
Wholesale	$	22,833		$	25,440
Retail	22,136			26,329
	$	44,969		$	51,769
	April 29, 2017			January 28, 2017
Total assets:
Wholesale	$	699,812		$	681,055
Retail	368,466			364,117
	1,068,278			1,045,172
Eliminations (a)	(763,539		)	(732,372		)
Consolidated assets	$	304,739		$	312,800

(a) Adjustment to eliminate intercompany receivables and investment in subsidiaries

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Apr. 29, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill [Table Text Block]

The following table provides information related to goodwill and intangible assets (in thousands). Intangible assets are included in intangible and other assets, net on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017:

		April 29, 2017						January 28, 2017
	Useful Life (years)	Original Cost		Accumulated Amortization		Net Book Value		Original Cost		Accumulated Amortization		Net Book Value
Goodwill	N/A	$	38,769	$	—	$	38,769	$	38,769	$	—	$	38,769
Tradenames	4-20	9,357		8,181		1,176		9,357		8,084		1,273
Customer relationships	10	5,171		2,629		2,542		5,171		2,500		2,671
Favorable leases	7	886		886		—		886		886		—
License agreements	3-5	16,313		15,779		534		16,313		15,643		670
Tradename (non-amortizing)	N/A	7,180		—		7,180		7,180		—		7,180
		$	77,676	$	27,475	$	50,201	$	77,676	$	27,113	$	50,563

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

As of April 29, 2017, estimated future amortization expense associated with intangible assets subject to amortization is as follows (in thousands):

Fiscal Year	Amortization Expense
Remainder of 2017	$	1,065
2018	877
2019	709
2020	684
2021	682
2022	235
	$	4,252

XML

Accounting For Share-Based Payments (Tables)

3 Months Ended

Apr. 29, 2017

ACCOUNTING FOR SHARE-BASED PAYMENTS [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following is a summary of the stock option activity during the thirteen weeks ended April 29, 2017:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 28, 2017	1,184,000		$	6.07
Granted	—		—
Exercised	—		—
Forfeited	(100,000	)	7.70
Outstanding as of April 29, 2017	1,084,000		$	5.92	6.9	$	—
Vested and expected to vest as of April 29, 2017	709,834		$	7.79	6.9	$	—
Exercisable as of April 29, 2017	709,834		$	7.79	6.9	$	—

Schedule of Share-based Compensation, Activity [Table Text Block]

The following is a summary of stock warrants activity during the thirteen weeks ended April 29, 2017:

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 28, 2017	6,299,971		$	11.80
Granted	—		—
Exercised	—		—
Forfeited	(2,133,332	)	8.00
Outstanding as of April 29, 2017	4,166,639		$	13.74	1.8	$	—
Vested and expected to vest as of April 29, 2017	4,166,639		$	13.74	1.8	$	—
Exercisable as of April 29, 2017	4,166,639		$	13.74	1.8	$	—

XML

Revolving Credit Facility and Notes Payable to Affiliates (Tables)

3 Months Ended

Apr. 29, 2017

REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES [Abstract]

Schedule of Debt [Table Text Block]

The Company’s revolving credit facility and notes payable to affiliates consist of the following:

	April 29, 2017		January 28, 2017
	(in thousands)
Revolving credit facility, interest payable monthly, secured by a pledge of substantially all of the Company's assets	$	4,517	$	—
Subordinated notes payable-affiliates	125,366		125,366
	129,883		125,366
Less current portion	—		—
Total long-term debt	$	129,883	$	125,366

XML

Related Party Transactions (Tables)

3 Months Ended

Apr. 29, 2017

Related Party Transactions [Abstract]

Schedule of Related Party Transactions [Table Text Block]

Transactions for merchandise purchases with these related companies during the thirteen-week periods ended April 29, 2017 and April 30, 2016 were as follows (in thousands):

	Total Purchases Thirteen Weeks Ended April 29, 2017		Total Purchases Thirteen Weeks Ended April 30, 2016		Balance Due April 29, 2017		Balance Due January 28, 2017
Lighthouse Companies	$	—	$	—	$	90	$	90
Jacavi	311		1,449		—		590
Quality King	—		13		—		—
Reba	—		122		357		337
	$	311	$	1,584	$	447	$	1,017

XML

Segment Information (Tables)

9 Months Ended

Oct. 29, 2016

SEGMENT INFORMATION [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for these segments is summarized in the following table:

	Thirteen Weeks Ended April 29, 2017			Thirteen Weeks Ended April 30, 2016
	(in thousands)
Net sales:
Wholesale	$	51,102		$	53,464
Retail	46,794			51,675
	$	97,896		$	105,139
Gross profit:
Wholesale	$	22,833		$	25,440
Retail	22,136			26,329
	$	44,969		$	51,769
	April 29, 2017			January 28, 2017
Total assets:
Wholesale	$	699,812		$	681,055
Retail	368,466			364,117
	1,068,278			1,045,172
Eliminations (a)	(763,539		)	(732,372		)
Consolidated assets	$	304,739		$	312,800

(a) Adjustment to eliminate intercompany receivables and investment in subsidiaries

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

ThisForm 10-Q, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by words or phrases such as “may,” “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target,” “forecast,” “objective,” “assume,” “strategies” and other words and terms of similar meaning. Forward-looking statements involve estimates, expectations, projections, goals, forecasts, assumptions, risks and uncertainties. We caution readers that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement.

Among the factors that could cause actual results, performance or achievement to differ materially from those described or implied in the forward-looking statements are our ability to service our obligations, our ability to comply with the covenants in our Senior Credit Facility, any deterioration of general economic conditions and weaker discretionary spending by consumers, due to various factors including the diminishing patronage by retail customers at malls where our stores are located and other factors included in our filings with the SEC. Copies of our SEC filings are available from the SEC or may be obtained upon request from us.

You should also consider carefully the statements under “Risk Factors” in our Form 10-K which address additional factors that could cause our actual results to differ from those set forth in the forward-looking statements and could materially and adversely affect our business, operating results and financial condition. We cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

XML

Basis of Presentation and Operations (Details)	3 Months Ended
	Apr. 29, 2017 store subsidiary segment
Subsidiaries [Line Items]
Number of subsidiaries | subsidiary	6
Number of Operating Segments | segment	2
Subsidaries, Perfumania [Member]
Subsidiaries [Line Items]
Number of Stores	240
Subsidiaries, Scents of Worth [Member]
Subsidiaries [Line Items]
Number of Stores	1,100
Subsidiaries, Scents of Worth [Member] | Kmart [Member]
Subsidiaries [Line Items]
Number of Stores	600
Maximum [Member] | Subsidaries, Perfumania [Member]
Subsidiaries [Line Items]
Product Pricing, Discount from Manufacturer's Suggested Retail Price	75.00%

XML

Allowance for Doubtful Accounts (Details) $ in Millions	Apr. 30, 2016 USD ($)
Receivables [Abstract]
Allowance for Doubtful Accounts Receivable	$ 1.7

XML

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 29, 2017	Apr. 30, 2016	Nov. 02, 2013	Jan. 28, 2017
Schedule of Goodwill and Intangible Assets [Line Items]
Goodwill, Original Cost	$ 38,769			$ 38,769
Goodwill, Net Book Value	38,769			38,769
Intangible Assets, Original Cost	77,676			77,676
Intangible Assets, Accumulated Amortization	27,475			27,113
Intangible Assets, Net Book Value	50,201			50,563
Amortization of Intangible Assets	400	$ 900
Trade Names [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Intangible Assets, Original Cost	9,357			9,357
Intangible Assets, Accumulated Amortization	8,181			8,084
Intangible Assets, Net Book Value	1,176			1,273
Customer Relationships [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Useful Life (in years)			10 years
Intangible Assets, Original Cost	5,171			5,171
Intangible Assets, Accumulated Amortization	2,629			2,500
Intangible Assets, Net Book Value	2,542			2,671
Lease Agreements [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Useful Life (in years)			7 years
Intangible Assets, Original Cost	886			886
Intangible Assets, Accumulated Amortization	886			886
Intangible Assets, Net Book Value	0			0
Licensing Agreements [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Intangible Assets, Original Cost	16,313			16,313
Intangible Assets, Accumulated Amortization	15,779			15,643
Intangible Assets, Net Book Value	534			670
Trademarks [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Intangible Assets, Original Cost	7,180			7,180
Intangible Assets, Accumulated Amortization	0			0
Intangible Assets, Net Book Value	$ 7,180			$ 7,180
Minimum [Member] | Trade Names [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Useful Life (in years)			4 years
Minimum [Member] | Licensing Agreements [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Useful Life (in years)			3 years
Maximum [Member] | Trade Names [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Useful Life (in years)			20 years
Maximum [Member] | Licensing Agreements [Member]
Schedule of Goodwill and Intangible Assets [Line Items]
Useful Life (in years)			5 years

XML

Goodwill and Intangible Assets - Schedule of Future Amortization (Details) $ in Thousands	Apr. 29, 2017 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of Current Fiscal Year	$ 1,065
2015	877
2016	709
2017	684
2018	682
2019	235
Total	$ 4,252

XML

Goodwill and Intangible Assets - Textuals (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016	Jan. 28, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 38,769		$ 38,769
Amortization of Intangible Assets	$ 400	$ 900

XML

Accounting For Share-Based Payments - Options (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 29, 2017	Oct. 29, 2016	Apr. 30, 2016	Oct. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 34	$ 13	$ 32	$ 43
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of period (number of shares)	1,184,000
Granted (number of shares)	0
Exercised (number of shares)	0
Forfeited (number of shares)	(100,000)
Outstanding at end of period (number of shares)	1,084,000
Vested and expected to vest at end of period (number of shares)	709,834
Exercisable at beginning of period (number of shares)	709,834
Outstanding at beginning of period (weighted average exercise price)	$ 6.07
Granted (weighted average exercise price)	0.00
Exercised (weighted average exercise price)	0.00
Forfeited (weighted average exercise price)	7.70
Outstanding at end of period (weighted average exercise price)	5.92
Vested and expected to vest at end of period (weighted average exercise price)	7.79
Exercisable at end of period (weighted average exercise price)	$ 7.79
Outstanding at end of period (weighted average remaining contractual life)	6 years 10 months 24 days
Vested and expected to vest at end of period (weighted average remaining contractual life)	6 years 10 months 24 days
Exercisable at end of period (weighted average remaining contractual life)	6 years 10 months 24 days
Outstanding at end of period (aggregate intrinsic value)	$ 0
Vested and expected to vest at end of period (aggregate intrinsic value)	0
Exercisable at end of period (aggregate intrinsic value)	$ 0

XML

Accounting For Share-Based Payments - Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 29, 2017	Oct. 29, 2016	Apr. 30, 2016	Oct. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 34	$ 13	$ 32	$ 43
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at beginning of period (number of warrants)	6,299,971
Granted (number of warrants)	0
Exercised (number of warrants)	0
Forfeited (number of warrants)	(2,133,332)
Outstanding at beginning of period (number of warrants)	4,166,639
Vested at end of period (number of warrants)	4,166,639
Exercisable at end of period (number of warrants)	4,166,639
Outstanding at beginning of period (weighted average exercise price)	$ 11.80
Granted (weighted average exercise price)	0.00
Exercised (number of warrants)	0.00
Forfeited (number of warrants)	8.00
Outstanding at end of period (weighted average exercise price)	13.74
Vested at end of period (number of warrants)	13.74
Exercisable at end of period (number of warrants)	$ 13.74
Outstanding at end of period (weighted average remaining contractual life)	1 year 9 months 18 days
Vested at end of period (weighted average remaining contractual life)	1 year 9 months 18 days
Exercisable at end of period (weighted average remaining contractual life)	1 year 9 months 18 days
Outstanding at end of period (aggregate intrinsic value)	$ 0
Vested at end of period (aggregate intrinsic value)	0
Exercisable at end of period (aggregate intrinsic value)	$ 0

XML

Accounting For Share-Based Payments - Textuals (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Oct. 29, 2016	Apr. 30, 2016	Oct. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Annual Percentage Increase in Shares Authorized	1.50%
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options	2,426,711
Share-based compensation expense	$ 34	$ 13	$ 32	$ 43
The 2010 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at end of period (number of shares)	1,059,252

XML

Revolving Credit Facility and Notes Payable to Affiliates - Schedule (Details) - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 28, 2017	Oct. 29, 2016	Jan. 30, 2016
REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES [Abstract]
Revolving credit facility	$ 4,517	$ 0	$ 4,517	$ 0
Subordinated notes payable, affiliates	$ 125,366	$ 125,366	125,366	125,366
Debt, current and noncurrent			129,883	125,366
Less current portion			0	0
Total long-term debt			$ 129,883	$ 125,366

XML

Revolving Credit Facility and Notes Payable to Affiliates - Textuals (Details) $ in Thousands	3 Months Ended				6 Months Ended	9 Months Ended
	Apr. 29, 2017 USD ($)	Oct. 29, 2016 USD ($) real_estate_trust	Apr. 30, 2016 USD ($)	Oct. 31, 2015 USD ($)	Jul. 30, 2016	Oct. 29, 2016 USD ($) real_estate_trust	Jan. 28, 2017 USD ($)	Jan. 30, 2016 USD ($)
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 175,000				$ 175,000
Line of Credit Facility, Covenant Terms, Minimum Availability		10,000				10,000
Line of Credit Facility, Remaining Borrowing Capacity		80,100				80,100
Letter of credit, available amount		25,000				25,000
Notes payable, affiliates	$ 125,366	125,366				125,366	$ 125,366	$ 125,366
Interest expense	$ 2,125		$ 1,707
Notes Payable, Related Parties [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Payments, Covenant Terms, Minimum Availability of Revolving Credit Facility, Alternative		$ 17,500				$ 17,500
Debt Instrument, Interest Payments, Covenant Terms, Minimum Availability of Revolving Credit Facility, Percent of Borrowing Base, Alternative		17.50%				17.50%
Debt Instrument, Covenant Terms, Minimum Fixed Charge Coverage Ratio						1.1
Interest expense		$ 2,100		$ 1,500
Interest Payable		$ 52,900				$ 52,900		$ 50,800
Reference Rate, Base Rate [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Interest Rate at Period End		5.00%				5.00%
Parent Company and Domestic Subsidiaries [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Collateral, Percent of Outstanding Equity Interests in Subsidiaries		100.00%				100.00%
Foreign Subsidiaries [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Collateral, Percent of Outstanding Equity Interests in Subsidiaries		66.00%				66.00%
Affiliates, Quality King Distributors, Inc. [Member]
Debt Instrument [Line Items]
Notes payable, affiliates		$ 35,000				$ 35,000
Affiliates, Quality King Distributors, Inc. [Member] | Notes Payable, Related Parties [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate					1.00%
Nussdorf Trusts [Member]
Debt Instrument [Line Items]
Notes payable, affiliates		$ 85,400				$ 85,400
Related Parties, Number of Estate Trusts Holding Notes | real_estate_trust		6				6
Nussdorf Trusts [Member] | Notes Payable, Related Parties [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate						2.00%
Glenn and Stephen Nussdorf [Member]
Debt Instrument [Line Items]
Notes payable, affiliates		$ 5,000				$ 5,000
Glenn and Stephen Nussdorf [Member] | Notes Payable, Related Parties [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate						1.00%
Debt Instrument, Interest Rate, Increase						2.00%

XML

Basic and Diluted Net Loss Per Common Share - Textuals (Details) - shares	3 Months Ended
	Apr. 29, 2017	Jul. 30, 2016	Apr. 30, 2016	Aug. 01, 2015
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	5,250,639	7,132,723	7,135,556	7,405,635

XML

Related Party Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended	9 Months Ended
	Apr. 18, 2012	Apr. 29, 2017	Apr. 30, 2016	Aug. 01, 2015	Oct. 29, 2016	Jan. 28, 2017
Related Party Transaction [Line Items]
Selling, General and Administrative Expenses		$ 50,932	$ 53,928
Related Party Transaction, Purchases from Related Party		311	1,584
Due to Related Parties, Current		447				$ 1,017
Reba Americas LLC [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties		1,100	700	$ 1,600	$ 2,400
Related Party Transaction, Purchases from Related Party		0	122
Due to Related Parties, Current		357				337
Accounts Receivable, Related Parties		600				400
Affiliates, Lighthouse [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Purchases from Related Party		0	0
Due to Related Parties, Current		90				90
Affiliates, Jacavi [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Purchases from Related Party		311	1,449
Due to Related Parties, Current		0				590
Affiliates, Quality King Distributors, Inc. [Member]
Related Party Transaction [Line Items]
Selling, General and Administrative Expenses		200
Related Party Transaction, Purchases from Related Party		0	$ 13
Due to Related Parties, Current		$ 0				$ 0
Affiliates, Shawn Carter Entities [Member]
Related Party Transaction [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1,599,999
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 8.00
License Agreement, Term of Agreement	5 years

XML

Related Party Transactions - Textuals (Details) ft² in Thousands, $ in Thousands	3 Months Ended				6 Months Ended	9 Months Ended
	Apr. 29, 2017 USD ($) ft² shares	Oct. 29, 2016 USD ($)	Apr. 30, 2016 USD ($)	Aug. 01, 2015 USD ($)	Aug. 01, 2015 USD ($)	Oct. 29, 2016 USD ($)	Oct. 31, 2015 USD ($)	Jan. 28, 2017 USD ($)	Jan. 30, 2016 USD ($)
Related Party Transaction [Line Items]
Selling, General and Administrative Expenses	$ 50,932		$ 53,928
Loss Contingency, Damages Sought, Value						$ 2,700
Glenn, Stephen and Arlene Nussdorf [Member]
Related Party Transaction [Line Items]
Investment Owned, Balance, Shares | shares	7,742,282
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	50.00%
Affiliates, Rene Garcia Entitites [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	14.30%
Noncontrolling Interest, Ownership by Noncontrolling Owners, Shares | shares	2,211,269
Reba Americas LLC [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties	$ 1,100		$ 700		$ 1,600	$ 2,400
Affiliates, GSN [Member]
Related Party Transaction [Line Items]
Shipping, Handling and Transportation Costs	$ 100
Affiliates, Quality King Distributors, Inc. [Member]
Related Party Transaction [Line Items]
Square Footage of Real Estate Property | ft²	560
Selling, General and Administrative Expense, Administrative Fee, Percent						2.00%
Selling, General and Administrative Expenses	$ 200
Due to Affiliate, Current	$ 100							$ 100	$ 100
Building [Member] | Affiliates, Quality King Distributors, Inc. [Member]
Related Party Transaction [Line Items]
Operating Leases, Rent Expense, Monthly						$ 240
Operating Leases, Rent Expense, Annual Increase						3.00%
Payments for Operating Sublease		$ 700		$ 700	$ 1,400		$ 2,000

XML

Segment Information (Details) - USD ($) $ in Thousands		3 Months Ended
		Apr. 29, 2017	Apr. 30, 2016	Jan. 28, 2017
Segment Reporting Information [Line Items]
Revenue from External Customers		$ 97,896	$ 105,139
Gross Profit		44,969	51,769
Assets		304,739		$ 312,800
Retail Segment [Member]
Segment Reporting Information [Line Items]
Revenue from External Customers		46,794	51,675
Gross Profit		22,136	26,329
Assets		368,466		364,117
Wholesale Segment [Member]
Segment Reporting Information [Line Items]
Revenue from External Customers		51,102	53,464
Gross Profit		22,833	$ 25,440
Assets		699,812		681,055
Operating Segments [Member]
Segment Reporting Information [Line Items]
Assets		1,068,278		1,045,172
Intersegment Elimination [Member]
Segment Reporting Information [Line Items]
Assets	[1]	$ (763,539)		$ (732,372)

[1] Adjustment to eliminate intercompany receivables and investment in subsidiaries